<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0">
    <channel>
        <title>Journal of the American Academy of Dermatology via MedWorm.com</title>
        <description>MedWorm.com provides a medical RSS filtering service. Over 6000 RSS medical sources are combined and output via different filters. This feed contains the latest items from the 'Journal of the American Academy of Dermatology' source.</description>
        <link><![CDATA[http://www.medworm.com/rss/search.php?qu=Journal+of+the+American+Academy+of+Dermatology&t=Journal+of+the+American+Academy+of+Dermatology&s=Search&f=source]]></link>
        <lastBuildDate>Wed, 08 Feb 2012 13:12:33 +0100</lastBuildDate>
        <item>
            <title>Dermatology Calendar</title>
            <link>http://www.medworm.com/index.php?rid=5597900&amp;cid=s_37696_12_f&amp;fid=37696&amp;url=http%3A%2F%2Fwww.eblue.org%2Farticle%2FPIIS0190962211023322%2Fabstract%3Frss%3Dyes</link>
            <description>(Source: Journal of the American Academy of Dermatology)</description>
            <author>Journal of the American Academy of Dermatology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5597900</comments>
            <pubDate>Tue, 17 Jan 2012 18:09:00 +0100</pubDate>
            <guid isPermaLink="false">5597900</guid>        </item>
        <item>
            <title>Information for Readers</title>
            <link>http://www.medworm.com/index.php?rid=5597899&amp;cid=s_37696_12_f&amp;fid=37696&amp;url=http%3A%2F%2Fwww.eblue.org%2Farticle%2FPIIS0190962211023310%2Fabstract%3Frss%3Dyes</link>
            <description>(Source: Journal of the American Academy of Dermatology)</description>
            <author>Journal of the American Academy of Dermatology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5597899</comments>
            <pubDate>Tue, 17 Jan 2012 18:09:00 +0100</pubDate>
            <guid isPermaLink="false">5597899</guid>        </item>
        <item>
            <title>Table of Contents</title>
            <link>http://www.medworm.com/index.php?rid=5597898&amp;cid=s_37696_12_f&amp;fid=37696&amp;url=http%3A%2F%2Fwww.eblue.org%2Farticle%2FPIIS0190962211023292%2Fabstract%3Frss%3Dyes</link>
            <description>(Source: Journal of the American Academy of Dermatology)</description>
            <author>Journal of the American Academy of Dermatology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5597898</comments>
            <pubDate>Tue, 17 Jan 2012 18:09:00 +0100</pubDate>
            <guid isPermaLink="false">5597898</guid>        </item>
        <item>
            <title>Editorial Board</title>
            <link>http://www.medworm.com/index.php?rid=5597897&amp;cid=s_37696_12_f&amp;fid=37696&amp;url=http%3A%2F%2Fwww.eblue.org%2Farticle%2FPIIS0190962211023309%2Fabstract%3Frss%3Dyes</link>
            <description>(Source: Journal of the American Academy of Dermatology)</description>
            <author>Journal of the American Academy of Dermatology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5597897</comments>
            <pubDate>Tue, 17 Jan 2012 18:09:00 +0100</pubDate>
            <guid isPermaLink="false">5597897</guid>        </item>
        <item>
            <title>January iotaderma (#216)</title>
            <link>http://www.medworm.com/index.php?rid=5597896&amp;cid=s_37696_12_f&amp;fid=37696&amp;url=http%3A%2F%2Fwww.eblue.org%2Farticle%2FPIIS0190962211007936%2Fabstract%3Frss%3Dyes</link>
            <description>(Source: Journal of the American Academy of Dermatology)</description>
            <author>Journal of the American Academy of Dermatology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5597896</comments>
            <pubDate>Tue, 17 Jan 2012 18:09:00 +0100</pubDate>
            <guid isPermaLink="false">5597896</guid>        </item>
        <item>
            <title>Iotaderma #217</title>
            <link>http://www.medworm.com/index.php?rid=5597895&amp;cid=s_37696_12_f&amp;fid=37696&amp;url=http%3A%2F%2Fwww.eblue.org%2Farticle%2FPIIS0190962210018153%2Fabstract%3Frss%3Dyes</link>
            <description>(Source: Journal of the American Academy of Dermatology)</description>
            <author>Journal of the American Academy of Dermatology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5597895</comments>
            <pubDate>Tue, 17 Jan 2012 18:09:00 +0100</pubDate>
            <guid isPermaLink="false">5597895</guid>        </item>
        <item>
            <title>Erosive plaques on the dorsal surfaces of the hands</title>
            <link>http://www.medworm.com/index.php?rid=5597890&amp;cid=s_37696_12_f&amp;fid=37696&amp;url=http%3A%2F%2Fwww.eblue.org%2Farticle%2FPIIS0190962211003136%2Fabstract%3Frss%3Dyes</link>
            <description>An otherwise healthy 58-year-old woman presents with a 10-day history of ulcers on the dorsal surfaces of both hands. The initial lesion, an expanding pustule, became bullous and erosive. She subsequently developed large bullous hemorrhagic plaques on both forearms. The patient denies systemic symptoms, oral or genital ulcers, sick contacts, recent travel, contact with chemicals, or new medications. The physical examination reveals large eroded exophytic erythematous plaques with overlying bullae on the dorsal surfaces of her hands and forearms (). An outside punch biopsy specimen is obtained and reveals a diffuse neutrophilic infiltrate throughout the dermis with focal vasculitis. Stains for fungi and bacteria are negative. A repeat biopsy is performed (). Based on clinical and histopatho...</description>
            <author>Journal of the American Academy of Dermatology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5597890</comments>
            <pubDate>Tue, 17 Jan 2012 18:08:59 +0100</pubDate>
            <guid isPermaLink="false">5597890</guid>        </item>
        <item>
            <title>An infant with persistent bullous urticaria</title>
            <link>http://www.medworm.com/index.php?rid=5597889&amp;cid=s_37696_12_f&amp;fid=37696&amp;url=http%3A%2F%2Fwww.eblue.org%2Farticle%2FPIIS0190962211000132%2Fabstract%3Frss%3Dyes</link>
            <description>A 6-month-old male presents with persistent urticaria that has been present since 1 month of age and that began after starting a course of oral ranitidine. The physical examination reveals striking dermatographism and numerous wheals on his trunk and extremities, some with superimposed vesicles and bullae. The distribution of lesions coincides with areas of friction, rubbing, and/or scratching, and the skin appears otherwise normal. Radioallergosorbent testing is negative for common food allergens, a complete blood cell count is normal, and the serum tryptase level is 112 μg/L (normal range, 0.4-10.9 μg/L). At 10 months of age, he develops a cobblestoned, doughy pattern on his upper extremities and trunk (). A 3-mm punch biopsy specimen is obtained and is stained with hematoxylin–eosin...</description>
            <author>Journal of the American Academy of Dermatology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5597889</comments>
            <pubDate>Tue, 17 Jan 2012 18:08:59 +0100</pubDate>
            <guid isPermaLink="false">5597889</guid>        </item>
        <item>
            <title>Red, purple, and brown skin lesions in a 2-month-old boy</title>
            <link>http://www.medworm.com/index.php?rid=5597888&amp;cid=s_37696_12_f&amp;fid=37696&amp;url=http%3A%2F%2Fwww.eblue.org%2Farticle%2FPIIS0190962210010571%2Fabstract%3Frss%3Dyes</link>
            <description>A 2-month-old boy presented with a homogenous and reticulated erythematous patch involving the right side of his face, mainly in the distribution of cranial nerve V1/V2 (). This erythematous to purple reticulation continued over the right half of the anterior surface of the patient’s trunk, right leg, and most of the posterior surface of the trunk (). The right lower extremity, left middle back, and lower back extending to the sacrum had darker blue-brown patches (). All of these patches had been present since birth. No limb hypertrophy, atrophy, or length discrepancy was noted. The patient had previously been diagnosed with glaucoma of the right eye. (Source: Journal of the American Academy of Dermatology)</description>
            <author>Journal of the American Academy of Dermatology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5597888</comments>
            <pubDate>Tue, 17 Jan 2012 18:08:59 +0100</pubDate>
            <guid isPermaLink="false">5597888</guid>        </item>
        <item>
            <title>A 40-year-old man with hyperkeratotic palms and soles</title>
            <link>http://www.medworm.com/index.php?rid=5597887&amp;cid=s_37696_12_f&amp;fid=37696&amp;url=http%3A%2F%2Fwww.eblue.org%2Farticle%2FPIIS019096221100137X%2Fabstract%3Frss%3Dyes</link>
            <description>A 40-year-old Hispanic man presented with thickened, fissured, and peeling palms and soles that had been present since childhood (). He was seen for a refill of his medication (acitretin 25 mg/day), which improved the symptoms. (Source: Journal of the American Academy of Dermatology)</description>
            <author>Journal of the American Academy of Dermatology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5597887</comments>
            <pubDate>Tue, 17 Jan 2012 18:08:59 +0100</pubDate>
            <guid isPermaLink="false">5597887</guid>        </item>
        <item>
            <title>JAAD Grand Rounds quiz∗ A 46-year-old man with agminated papules on the buttock</title>
            <link>http://www.medworm.com/index.php?rid=5597886&amp;cid=s_37696_12_f&amp;fid=37696&amp;url=http%3A%2F%2Fwww.eblue.org%2Farticle%2FPIIS0190962210004858%2Fabstract%3Frss%3Dyes</link>
            <description>Instructions: In answering each question, refer to the specific directions provided. Because it is often necessary to provide information occurring later in a series that gives away answers to earlier questions, please answer the questions in each series in sequence. (Source: Journal of the American Academy of Dermatology)</description>
            <author>Journal of the American Academy of Dermatology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5597886</comments>
            <pubDate>Tue, 17 Jan 2012 18:08:59 +0100</pubDate>
            <guid isPermaLink="false">5597886</guid>        </item>
        <item>
            <title>Use of a hydrocolloid dressing to aid in the closure of surgical wounds in patients with fragile skin</title>
            <link>http://www.medworm.com/index.php?rid=5597885&amp;cid=s_37696_12_f&amp;fid=37696&amp;url=http%3A%2F%2Fwww.eblue.org%2Farticle%2FPIIS0190962210014805%2Fabstract%3Frss%3Dyes</link>
            <description>To the Editor: When repairing surgical defects in patients with thin, fragile skin, it can sometimes be difficult to suture wounds without tearing through cutaneous layers, particularly for distal extremity defects in elderly patients with extreme photodamage. Additional comorbidities, such as prolonged systemic steroid use, can further complicate closures in these patients. In these extreme cases the dermis is too thin to anchor deep sutures, and attempts with full-thickness superficial sutures result in skin tearing if the wound is under tension. This necessitates the use of other techniques or devices to aid in the closure of these surgical defects. (Source: Journal of the American Academy of Dermatology)</description>
            <author>Journal of the American Academy of Dermatology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5597885</comments>
            <pubDate>Tue, 17 Jan 2012 18:08:59 +0100</pubDate>
            <guid isPermaLink="false">5597885</guid>        </item>
        <item>
            <title>Phaeohyphomycosis caused by Phaeoacremonium species in a patient taking infliximab</title>
            <link>http://www.medworm.com/index.php?rid=5597884&amp;cid=s_37696_12_f&amp;fid=37696&amp;url=http%3A%2F%2Fwww.eblue.org%2Farticle%2FPIIS0190962210004871%2Fabstract%3Frss%3Dyes</link>
            <description>We report a 74-year-old man with a history of severe rheumatoid arthritis treated with infliximab who presented with a slowly enlarging nodule on his posterior left leg. The lesion began as a small red bump approximately 1 month after being stuck with a thorn of a pyracantha bush. The bump grew in size over 4 months and was unresponsive to multiple oral antibiotics. Bacterial cultures were negative. The patient did not complain of any systemic symptoms. Physical examination showed a 1.5- × 4-cm violaceous scaling and crusted nodule on the posterior aspect of his left leg (). No lymphadenopathy was present. (Source: Journal of the American Academy of Dermatology)</description>
            <author>Journal of the American Academy of Dermatology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5597884</comments>
            <pubDate>Tue, 17 Jan 2012 18:08:59 +0100</pubDate>
            <guid isPermaLink="false">5597884</guid>        </item>
        <item>
            <title>Grover disease may result from the impairment of keratinocytic cholinergic receptors</title>
            <link>http://www.medworm.com/index.php?rid=5597883&amp;cid=s_37696_12_f&amp;fid=37696&amp;url=http%3A%2F%2Fwww.eblue.org%2Farticle%2FPIIS0190962209009931%2Fabstract%3Frss%3Dyes</link>
            <description>To the Editor: Grover disease is an eruption of intraepidermal acantholysis presenting as crusted reddened papules; it is usually found on the trunk of middle aged patients, with a male to female ratio of 2:1. The disease may be transient or persistent. Although the onset of Grover disease often appears to be spontaneous, the expression of Grover disease has been associated with a multitude of factors, including sun exposure, winter time, interleukin-4 administration, heat or sweat, ionizing radiation, psoralen plus ultraviolet A light phototherapy, chemotherapy, and chronic renal failure. Causation has not been established. (Source: Journal of the American Academy of Dermatology)</description>
            <author>Journal of the American Academy of Dermatology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5597883</comments>
            <pubDate>Tue, 17 Jan 2012 18:08:59 +0100</pubDate>
            <guid isPermaLink="false">5597883</guid>        </item>
        <item>
            <title>Infliximab as a steroid-sparing agent in refractory cutaneous sarcoidosis: Single-center retrospective study of 9 patients</title>
            <link>http://www.medworm.com/index.php?rid=5597882&amp;cid=s_37696_12_f&amp;fid=37696&amp;url=http%3A%2F%2Fwww.eblue.org%2Farticle%2FPIIS0190962211006220%2Fabstract%3Frss%3Dyes</link>
            <description>To the Editor: Therapeutic options for cutaneous sarcoidosis are limited. Several reports of successful treatment of cutaneous sarcoidosis with anti-tumor necrosis factor have been published. We aimed to evaluate our experience with the use of infliximab in refractory cutaneous sarcoidosis. (Source: Journal of the American Academy of Dermatology)</description>
            <author>Journal of the American Academy of Dermatology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5597882</comments>
            <pubDate>Tue, 17 Jan 2012 18:08:59 +0100</pubDate>
            <guid isPermaLink="false">5597882</guid>        </item>
        <item>
            <title>Randomized study of topical tacrolimus ointment as possible treatment for resistant idiopathic pruritus ani</title>
            <link>http://www.medworm.com/index.php?rid=5597881&amp;cid=s_37696_12_f&amp;fid=37696&amp;url=http%3A%2F%2Fwww.eblue.org%2Farticle%2FPIIS0190962211005998%2Fabstract%3Frss%3Dyes</link>
            <description>To the Editor: Pruritus ani (PA) is a common and embarrassing proctologic condition, which can be difficult to treat if there are no obvious predisposing factors. There is little scientific evidence concerning the treatment of idiopathic PA. Randomized controlled studies have been published for both 1% hydrocortisone ointment (symptom reduction in 68% of patients after 2 weeks’ treatment compared with placebo) and capsaicin 0.006% (70% with relieved itching compared with 2% with placebo after 4 weeks 3 times daily). Intradermal injection of methylene blue is frequently reported, but no randomized studies have been done. Prolonged topical steroid use may provoke skin atrophy. Topical tacrolimus is proposed as an alternative treatment for inflammatory skin diseases in thin skin areas. (Sou...</description>
            <author>Journal of the American Academy of Dermatology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5597881</comments>
            <pubDate>Tue, 17 Jan 2012 18:08:58 +0100</pubDate>
            <guid isPermaLink="false">5597881</guid>        </item>
        <item>
            <title>Long-term prognosis of vitiligo patients on narrowband UVB phototherapy</title>
            <link>http://www.medworm.com/index.php?rid=5597880&amp;cid=s_37696_12_f&amp;fid=37696&amp;url=http%3A%2F%2Fwww.eblue.org%2Farticle%2FPIIS0190962211011777%2Fabstract%3Frss%3Dyes</link>
            <description>To the Editor: We read with interest the CME article on vitiligo that mentioned the paucity of long-term follow-up data of narrowband ultraviolet B (NB-UVB) therapy in vitiligo. Although there are no established treatment caps for NB-UVB, the suggested limit for skin types I-III is arbitrarily set at 200 treatments. While there is no set limit for skin types IV-VI, the recommendation for number of treatments should be based on clinician discretion and patient consent. We have observed that long-term NB-UVB in vitiligo patients is safe. This is important because these patients often require more than 12 to 24 months of treatment for repigmentation. (Source: Journal of the American Academy of Dermatology)</description>
            <author>Journal of the American Academy of Dermatology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5597880</comments>
            <pubDate>Tue, 17 Jan 2012 18:08:58 +0100</pubDate>
            <guid isPermaLink="false">5597880</guid>        </item>
        <item>
            <title>Reply</title>
            <link>http://www.medworm.com/index.php?rid=5597879&amp;cid=s_37696_12_f&amp;fid=37696&amp;url=http%3A%2F%2Fwww.eblue.org%2Farticle%2FPIIS0190962211010097%2Fabstract%3Frss%3Dyes</link>
            <description>To the Editor: We would disagree with the primary argument put forward by Torchia in response to our article “Melanoma(s) arising in large segmental speckled lentiginous nevi (SLN): A case series,” which disputes the diagnosis of SLN in all 4 cases described. (Source: Journal of the American Academy of Dermatology)</description>
            <author>Journal of the American Academy of Dermatology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5597879</comments>
            <pubDate>Tue, 17 Jan 2012 18:08:58 +0100</pubDate>
            <guid isPermaLink="false">5597879</guid>        </item>
        <item>
            <title>Segmentally grouped melanocytic nevi and melanoma risk</title>
            <link>http://www.medworm.com/index.php?rid=5597878&amp;cid=s_37696_12_f&amp;fid=37696&amp;url=http%3A%2F%2Fwww.eblue.org%2Farticle%2FPIIS0190962211010061%2Fabstract%3Frss%3Dyes</link>
            <description>To the Editor: In the June 2011 issue of the JAAD, Ly et al reported a 4-case series on malignant melanoma (MM) arising on speckled lentiginous nevus (SLN). It is my opinion that none of those cases can be classified as SLN because by definition SLN, either of the macular or papular type, is characterized by a homogeneous hyperpigmented background which defines the size of the lesion and is virtually indistinguishable from café-au-lait spots (CALs) as of color and histologic features. Instead, in all 4 cases, lentigines (and often CALs) were present in a block-like segmental pattern, and a hyperpigmented background was evidently absent as it would have made invisible the lentigines and, mostly, CALs. Taken all together, these features are instead pathognomonic for partial unilateral lent...</description>
            <author>Journal of the American Academy of Dermatology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5597878</comments>
            <pubDate>Tue, 17 Jan 2012 18:08:58 +0100</pubDate>
            <guid isPermaLink="false">5597878</guid>        </item>
        <item>
            <title>Limitations of the “spaghetti technique”</title>
            <link>http://www.medworm.com/index.php?rid=5597877&amp;cid=s_37696_12_f&amp;fid=37696&amp;url=http%3A%2F%2Fwww.eblue.org%2Farticle%2FPIIS0190962211006888%2Fabstract%3Frss%3Dyes</link>
            <description>To the Editor: We read with great interest the recent article by Gaudy-Marqueste et al entitled “The ‘‘spaghetti technique’’: An alternative to Mohs surgery or staged surgery for problematic lentiginous melanoma (lentigo maligna and acral lentiginous melanoma)” in the January 2011 edition of the Journal. The authors introduced a two-phase procedure (spaghetti technique), which seems to be a modification of the “square technique” described in 1997 by Johnson et al. We agree with the authors that the spaghetti technique provides a comprehensive longitudinal en face dermatopathologic control of the periphery. However, in our opinion, the technique has some disadvantages. The major drawback of the spaghetti technique is that the central tumor is not excised until the time of ...</description>
            <author>Journal of the American Academy of Dermatology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5597877</comments>
            <pubDate>Tue, 17 Jan 2012 18:08:58 +0100</pubDate>
            <guid isPermaLink="false">5597877</guid>        </item>
        <item>
            <title>Biopharmaceuticals and biosimilars in psoriasis: What the dermatologist needs to know</title>
            <link>http://www.medworm.com/index.php?rid=5597876&amp;cid=s_37696_12_f&amp;fid=37696&amp;url=http%3A%2F%2Fwww.eblue.org%2Farticle%2FPIIS0190962211010188%2Fabstract%3Frss%3Dyes</link>
            <description>The entry of biosimilar forms of biopharmaceutical therapies for the treatment of psoriasis and other immune-mediated disorders has provoked considerable interest. Although dermatologists are accustomed to the use of a wide range of generic topical agents, recognition of key differences between original agent (ie, the name brand) and the generic or biosimilar agent is necessary to support optimal therapy management and patient care. In this review we have summarized the current state of the art related to the impending introduction of biosimilars into dermatology. Biosimilars represent important interventions that are less expensive and hence offer the potential to deliver benefit to large numbers of patients who may not currently be able to access these therapies. But the development of b...</description>
            <author>Journal of the American Academy of Dermatology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5597876</comments>
            <pubDate>Tue, 17 Jan 2012 18:08:58 +0100</pubDate>
            <guid isPermaLink="false">5597876</guid>        </item>
        <item>
            <title>American Board of Dermatology Examination Dates</title>
            <link>http://www.medworm.com/index.php?rid=5597863&amp;cid=s_37696_12_f&amp;fid=37696&amp;url=http%3A%2F%2Fwww.eblue.org%2Farticle%2FPIIS0190962211023498%2Fabstract%3Frss%3Dyes</link>
            <description>(Source: Journal of the American Academy of Dermatology)</description>
            <author>Journal of the American Academy of Dermatology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5597863</comments>
            <pubDate>Tue, 17 Jan 2012 18:08:57 +0100</pubDate>
            <guid isPermaLink="false">5597863</guid>        </item>
        <item>
            <title>Answers to CME examination</title>
            <link>http://www.medworm.com/index.php?rid=5597862&amp;cid=s_37696_12_f&amp;fid=37696&amp;url=http%3A%2F%2Fwww.eblue.org%2Farticle%2FPIIS019096221101200X%2Fabstract%3Frss%3Dyes</link>
            <description>(Source: Journal of the American Academy of Dermatology)</description>
            <author>Journal of the American Academy of Dermatology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5597862</comments>
            <pubDate>Tue, 17 Jan 2012 18:08:57 +0100</pubDate>
            <guid isPermaLink="false">5597862</guid>        </item>
        <item>
            <title>CME examination</title>
            <link>http://www.medworm.com/index.php?rid=5597861&amp;cid=s_37696_12_f&amp;fid=37696&amp;url=http%3A%2F%2Fwww.eblue.org%2Farticle%2FPIIS0190962211011996%2Fabstract%3Frss%3Dyes</link>
            <description>(Source: Journal of the American Academy of Dermatology)</description>
            <author>Journal of the American Academy of Dermatology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5597861</comments>
            <pubDate>Tue, 17 Jan 2012 18:08:57 +0100</pubDate>
            <guid isPermaLink="false">5597861</guid>        </item>
        <item>
            <title>Solar cheilosis: An ominous precursor: Part II. Therapeutic perspectives</title>
            <link>http://www.medworm.com/index.php?rid=5597860&amp;cid=s_37696_12_f&amp;fid=37696&amp;url=http%3A%2F%2Fwww.eblue.org%2Farticle%2FPIIS0190962211011959%2Fabstract%3Frss%3Dyes</link>
            <description>The differential diagnosis of SC includes malignant, premalignant, metastatic, inflammatory, and eczematoid disorders, along with photodermatoses and a few rare but important disorders of the lower lip. Current treatment options include topical, ablative, and surgical therapies. Several clinical challenges are also addressed, including the issue of obtaining a high-yield diagnostic biopsy specimen while minimizing patient morbidity, field-directed treatment for SC, and strategies for combination therapy. (Source: Journal of the American Academy of Dermatology)</description>
            <author>Journal of the American Academy of Dermatology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5597860</comments>
            <pubDate>Tue, 17 Jan 2012 18:08:57 +0100</pubDate>
            <guid isPermaLink="false">5597860</guid>        </item>
        <item>
            <title>Change of Address</title>
            <link>http://www.medworm.com/index.php?rid=5597859&amp;cid=s_37696_12_f&amp;fid=37696&amp;url=http%3A%2F%2Fwww.eblue.org%2Farticle%2FPIIS0190962211023486%2Fabstract%3Frss%3Dyes</link>
            <description>(Source: Journal of the American Academy of Dermatology)</description>
            <author>Journal of the American Academy of Dermatology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5597859</comments>
            <pubDate>Tue, 17 Jan 2012 18:08:57 +0100</pubDate>
            <guid isPermaLink="false">5597859</guid>        </item>
        <item>
            <title>Answers to CME examination</title>
            <link>http://www.medworm.com/index.php?rid=5597858&amp;cid=s_37696_12_f&amp;fid=37696&amp;url=http%3A%2F%2Fwww.eblue.org%2Farticle%2FPIIS0190962211011984%2Fabstract%3Frss%3Dyes</link>
            <description>(Source: Journal of the American Academy of Dermatology)</description>
            <author>Journal of the American Academy of Dermatology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5597858</comments>
            <pubDate>Tue, 17 Jan 2012 18:08:57 +0100</pubDate>
            <guid isPermaLink="false">5597858</guid>        </item>
        <item>
            <title>CME examination</title>
            <link>http://www.medworm.com/index.php?rid=5597857&amp;cid=s_37696_12_f&amp;fid=37696&amp;url=http%3A%2F%2Fwww.eblue.org%2Farticle%2FPIIS0190962211011972%2Fabstract%3Frss%3Dyes</link>
            <description>(Source: Journal of the American Academy of Dermatology)</description>
            <author>Journal of the American Academy of Dermatology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5597857</comments>
            <pubDate>Tue, 17 Jan 2012 18:08:57 +0100</pubDate>
            <guid isPermaLink="false">5597857</guid>        </item>
        <item>
            <title>Solar cheilosis: An ominous precursor: Part I. Diagnostic insights</title>
            <link>http://www.medworm.com/index.php?rid=5597856&amp;cid=s_37696_12_f&amp;fid=37696&amp;url=http%3A%2F%2Fwww.eblue.org%2Farticle%2FPIIS0190962211011960%2Fabstract%3Frss%3Dyes</link>
            <description>Squamous cell carcinoma (SCC) of the lower lip is a deadly nonmelanoma skin cancer. Its precursor, a distinctive cutaneous neoplasia analogous to cervical dysplasia, is known by the confusing term actinic cheilitis. Solar cheilosis (SC) is a more appropriate designation. It represents incipient SCC in situ. SC is widely recognized as an ultraviolet light–induced precancer of the lower lip that is typically seen in light-skinned individuals and others with poorly pigmented lower lips. Lip SCC is one of the most common malignancies of the oral cavity. SCC is much more likely to metastasize from the lip than cutaneous surfaces, with a 5-year overall survival rate of less than 75%. SC results from long-term exposure to ultraviolet radiation. The occurrence of SC is dose-dependent and is infl...</description>
            <author>Journal of the American Academy of Dermatology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5597856</comments>
            <pubDate>Tue, 17 Jan 2012 18:08:57 +0100</pubDate>
            <guid isPermaLink="false">5597856</guid>        </item>
        <item>
            <title>Information for Readers</title>
            <link>http://www.medworm.com/index.php?rid=5515564&amp;cid=s_37696_12_f&amp;fid=37696&amp;url=http%3A%2F%2Fwww.eblue.org%2Farticle%2FPIIS0190962211021554%2Fabstract%3Frss%3Dyes</link>
            <description>(Source: Journal of the American Academy of Dermatology)</description>
            <author>Journal of the American Academy of Dermatology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5515564</comments>
            <pubDate>Mon, 19 Dec 2011 05:52:16 +0100</pubDate>
            <guid isPermaLink="false">5515564</guid>        </item>
        <item>
            <title>Authors' Rights Statement</title>
            <link>http://www.medworm.com/index.php?rid=5515563&amp;cid=s_37696_12_f&amp;fid=37696&amp;url=http%3A%2F%2Fwww.eblue.org%2Farticle%2FPIIS0190962211021608%2Fabstract%3Frss%3Dyes</link>
            <description>(Source: Journal of the American Academy of Dermatology)</description>
            <author>Journal of the American Academy of Dermatology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5515563</comments>
            <pubDate>Mon, 19 Dec 2011 05:52:16 +0100</pubDate>
            <guid isPermaLink="false">5515563</guid>        </item>
        <item>
            <title>Conflict of Interest Disclosure</title>
            <link>http://www.medworm.com/index.php?rid=5515562&amp;cid=s_37696_12_f&amp;fid=37696&amp;url=http%3A%2F%2Fwww.eblue.org%2Farticle%2FPIIS0190962211021591%2Fabstract%3Frss%3Dyes</link>
            <description>(Source: Journal of the American Academy of Dermatology)</description>
            <author>Journal of the American Academy of Dermatology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5515562</comments>
            <pubDate>Mon, 19 Dec 2011 05:52:16 +0100</pubDate>
            <guid isPermaLink="false">5515562</guid>        </item>
        <item>
            <title>Authorship Declaration Form</title>
            <link>http://www.medworm.com/index.php?rid=5515561&amp;cid=s_37696_12_f&amp;fid=37696&amp;url=http%3A%2F%2Fwww.eblue.org%2Farticle%2FPIIS0190962211021542%2Fabstract%3Frss%3Dyes</link>
            <description>(Source: Journal of the American Academy of Dermatology)</description>
            <author>Journal of the American Academy of Dermatology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5515561</comments>
            <pubDate>Mon, 19 Dec 2011 05:52:16 +0100</pubDate>
            <guid isPermaLink="false">5515561</guid>        </item>
        <item>
            <title>Transfer of Copyright Form</title>
            <link>http://www.medworm.com/index.php?rid=5515560&amp;cid=s_37696_12_f&amp;fid=37696&amp;url=http%3A%2F%2Fwww.eblue.org%2Farticle%2FPIIS0190962211021530%2Fabstract%3Frss%3Dyes</link>
            <description>(Source: Journal of the American Academy of Dermatology)</description>
            <author>Journal of the American Academy of Dermatology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5515560</comments>
            <pubDate>Mon, 19 Dec 2011 05:52:16 +0100</pubDate>
            <guid isPermaLink="false">5515560</guid>        </item>
        <item>
            <title>Information for Authors</title>
            <link>http://www.medworm.com/index.php?rid=5515559&amp;cid=s_37696_12_f&amp;fid=37696&amp;url=http%3A%2F%2Fwww.eblue.org%2Farticle%2FPIIS0190962211021529%2Fabstract%3Frss%3Dyes</link>
            <description>(Source: Journal of the American Academy of Dermatology)</description>
            <author>Journal of the American Academy of Dermatology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5515559</comments>
            <pubDate>Mon, 19 Dec 2011 05:52:16 +0100</pubDate>
            <guid isPermaLink="false">5515559</guid>        </item>
        <item>
            <title>Table of Contents</title>
            <link>http://www.medworm.com/index.php?rid=5515558&amp;cid=s_37696_12_f&amp;fid=37696&amp;url=http%3A%2F%2Fwww.eblue.org%2Farticle%2FPIIS0190962211021505%2Fabstract%3Frss%3Dyes</link>
            <description>(Source: Journal of the American Academy of Dermatology)</description>
            <author>Journal of the American Academy of Dermatology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5515558</comments>
            <pubDate>Mon, 19 Dec 2011 05:52:16 +0100</pubDate>
            <guid isPermaLink="false">5515558</guid>        </item>
        <item>
            <title>Editorial Board</title>
            <link>http://www.medworm.com/index.php?rid=5515557&amp;cid=s_37696_12_f&amp;fid=37696&amp;url=http%3A%2F%2Fwww.eblue.org%2Farticle%2FPIIS0190962211021517%2Fabstract%3Frss%3Dyes</link>
            <description>(Source: Journal of the American Academy of Dermatology)</description>
            <author>Journal of the American Academy of Dermatology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5515557</comments>
            <pubDate>Mon, 19 Dec 2011 05:52:16 +0100</pubDate>
            <guid isPermaLink="false">5515557</guid>        </item>
        <item>
            <title>December iotaderma (#215)</title>
            <link>http://www.medworm.com/index.php?rid=5515556&amp;cid=s_37696_12_f&amp;fid=37696&amp;url=http%3A%2F%2Fwww.eblue.org%2Farticle%2FPIIS0190962211007948%2Fabstract%3Frss%3Dyes</link>
            <description>(Source: Journal of the American Academy of Dermatology)</description>
            <author>Journal of the American Academy of Dermatology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5515556</comments>
            <pubDate>Mon, 19 Dec 2011 05:52:16 +0100</pubDate>
            <guid isPermaLink="false">5515556</guid>        </item>
        <item>
            <title>Iotaderma #216</title>
            <link>http://www.medworm.com/index.php?rid=5515555&amp;cid=s_37696_12_f&amp;fid=37696&amp;url=http%3A%2F%2Fwww.eblue.org%2Farticle%2FPIIS0190962210007760%2Fabstract%3Frss%3Dyes</link>
            <description>(Source: Journal of the American Academy of Dermatology)</description>
            <author>Journal of the American Academy of Dermatology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5515555</comments>
            <pubDate>Mon, 19 Dec 2011 05:52:16 +0100</pubDate>
            <guid isPermaLink="false">5515555</guid>        </item>
        <item>
            <title>Conflict of interest and disclosure: Analysis of American Academy of Dermatology Annual Meetings</title>
            <link>http://www.medworm.com/index.php?rid=5515552&amp;cid=s_37696_12_f&amp;fid=37696&amp;url=http%3A%2F%2Fwww.eblue.org%2Farticle%2FPIIS0190962211004774%2Fabstract%3Frss%3Dyes</link>
            <description>To the Editor: When individuals have both a financial relationship with a commercial interest and the opportunity to affect the content of continuing medical education (CME) about the products or services of that commercial interest, conflicts of interest (COI) exist. Faculty, planners, and speakers at national dermatology CME meetings often have COI. It is the job of CME providers like the American Academy of Dermatology (AAD) to resolve COI to avoid commercial bias. Disclosure of these relationships is an important first step in the process to identify COI. Disclosure slides at the beginning of presentations also remind speakers and audiences of these relationships and allow audiences to decide whether commercial bias exists. The study’s objectives were to determine usage rates of spea...</description>
            <author>Journal of the American Academy of Dermatology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5515552</comments>
            <pubDate>Mon, 19 Dec 2011 05:52:16 +0100</pubDate>
            <guid isPermaLink="false">5515552</guid>        </item>
        <item>
            <title>Increasing prevalence of antimicrobial resistance among gram-negative isolates in patients with pemphigus vulgaris</title>
            <link>http://www.medworm.com/index.php?rid=5515550&amp;cid=s_37696_12_f&amp;fid=37696&amp;url=http%3A%2F%2Fwww.eblue.org%2Farticle%2FPIIS0190962211002416%2Fabstract%3Frss%3Dyes</link>
            <description>To the Editor: Recent data have suggested an association between the overuse of antibiotics for the acquisition of antibiotic resistance. It has been observed that in hospitalized patients there is increased emergence and spread of antibiotic-resistant pathogens, particularly multi-resistant gram-negative bacteria (GNB). We observed the same trend in patients with pemphigus vulgaris (PV), in whom infection remains the major cause of death. Delay in treating these infections and the increasing resistance to several antibiotics have been associated with poor outcomes. Extended-spectrum β-lactamases (ESBL) are often found in GNB, particularly Klebsiella spp, Escherichia coli, and Pseudomonas aeruginosa. Usually, this process occurs as the result of cross-infection with resistant organisms du...</description>
            <author>Journal of the American Academy of Dermatology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5515550</comments>
            <pubDate>Mon, 19 Dec 2011 05:52:16 +0100</pubDate>
            <guid isPermaLink="false">5515550</guid>        </item>
        <item>
            <title>Epidemiological, clinical, and therapeutic pattern of Mycobacterium marinum infection: A retrospective series of 35 cases from southern France</title>
            <link>http://www.medworm.com/index.php?rid=5515549&amp;cid=s_37696_12_f&amp;fid=37696&amp;url=http%3A%2F%2Fwww.eblue.org%2Farticle%2FPIIS0190962211001332%2Fabstract%3Frss%3Dyes</link>
            <description>To the Editor: Despite some data favoring clarithromycin, there is still considerable variation in the antibiotic regimens used to treat Mycobacterium marinum Data from 35 consecutive individuals, including 4 immunosuppressed patients with primary infection by M marinum identified in our institution from January 1994 to December 2007 were retrospectively investigated for the results of empiric antibiotic treatment. (Source: Journal of the American Academy of Dermatology)</description>
            <author>Journal of the American Academy of Dermatology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5515549</comments>
            <pubDate>Mon, 19 Dec 2011 05:52:16 +0100</pubDate>
            <guid isPermaLink="false">5515549</guid>        </item>
        <item>
            <title>Aprepitant: Evidence of its effectiveness in patients with refractory pruritus continues</title>
            <link>http://www.medworm.com/index.php?rid=5515548&amp;cid=s_37696_12_f&amp;fid=37696&amp;url=http%3A%2F%2Fwww.eblue.org%2Farticle%2FPIIS0190962211001253%2Fabstract%3Frss%3Dyes</link>
            <description>We report the alleviation of pruritus in two patients with refractory pruritus secondary to cutaneous lymphomas. Two patients, both with Sézary syndrome (one previously treated with bexarotene, chemotherapy [CHOP regimen], and alemtuzumab and the second with PUVA, bexarotene, and chemotherapy [CHOP regimen]) reported severe pruritus resistant to topical and oral corticosteroids, antihistamines and antidepressants, which affected not only their daily activities but also their sleep, translated into a important impact in their quality of life. (Source: Journal of the American Academy of Dermatology)</description>
            <author>Journal of the American Academy of Dermatology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5515548</comments>
            <pubDate>Mon, 19 Dec 2011 05:52:16 +0100</pubDate>
            <guid isPermaLink="false">5515548</guid>        </item>
        <item>
            <title>A World Wide Web–based survey of nonmedical tattooing in the United States</title>
            <link>http://www.medworm.com/index.php?rid=5515547&amp;cid=s_37696_12_f&amp;fid=37696&amp;url=http%3A%2F%2Fwww.eblue.org%2Farticle%2FPIIS0190962210021481%2Fabstract%3Frss%3Dyes</link>
            <description>To the Editor: In the United States, recent surveys suggest an increasing prevalence of nonmedical tattooing in younger age cohorts compared with surveys performed only a few years earlier. Given the high use of the Internet by young adults, we sought to estimate the current national prevalence of nonmedical tattoos using a widely disseminated online health assessment system called HowsYourHealth.org open to researchers. This system asks individuals to answer questions about their health status, symptoms, concerns, management of chronic diseases, health care experiences, and self-care. During the period from September to November 2008, we posted two additional questions on the World Wide Web site for respondents aged 14 to 69 years: (1) Have you ever had a tattoo on any part of your body...</description>
            <author>Journal of the American Academy of Dermatology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5515547</comments>
            <pubDate>Mon, 19 Dec 2011 05:52:16 +0100</pubDate>
            <guid isPermaLink="false">5515547</guid>        </item>
        <item>
            <title>A significant association exists between the severity of nail and skin involvement in psoriasis</title>
            <link>http://www.medworm.com/index.php?rid=5515546&amp;cid=s_37696_12_f&amp;fid=37696&amp;url=http%3A%2F%2Fwww.eblue.org%2Farticle%2FPIIS0190962210020050%2Fabstract%3Frss%3Dyes</link>
            <description>To the Editor: Nail psoriasis is reported to affect most patients with psoriasis at some point in their lives. It has been shown to be associated with longer duration of skin lesions. In addition, there is a positive association between the duration of psoriasis and the severity of nail involvement. However, the relationship between the severity of nail involvement and the extent of skin lesions has not been well understood. The main purpose of this study was to assess the relationship between the severity of nail involvement using the Nail Psoriasis Severity Index (NAPSI) and the extent of plaque-type psoriasis disease by using the Psoriasis Area and Severity Index (PASI). (Source: Journal of the American Academy of Dermatology)</description>
            <author>Journal of the American Academy of Dermatology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5515546</comments>
            <pubDate>Mon, 19 Dec 2011 05:52:16 +0100</pubDate>
            <guid isPermaLink="false">5515546</guid>        </item>
        <item>
            <title>Relation between treatment efficacy and cumulative dose of 3% topical minoxidil in male pattern baldness</title>
            <link>http://www.medworm.com/index.php?rid=5515545&amp;cid=s_37696_12_f&amp;fid=37696&amp;url=http%3A%2F%2Fwww.eblue.org%2Farticle%2FPIIS0190962210019912%2Fabstract%3Frss%3Dyes</link>
            <description>The objective of this study was to evaluate the association between efficacy and cumulative dose of topical minoxidil solution in the treatment of AGA during a 24-week period. (Source: Journal of the American Academy of Dermatology)</description>
            <author>Journal of the American Academy of Dermatology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5515545</comments>
            <pubDate>Mon, 19 Dec 2011 05:52:16 +0100</pubDate>
            <guid isPermaLink="false">5515545</guid>        </item>
        <item>
            <title>Sun-protection behaviors of melanoma survivors</title>
            <link>http://www.medworm.com/index.php?rid=5515544&amp;cid=s_37696_12_f&amp;fid=37696&amp;url=http%3A%2F%2Fwww.eblue.org%2Farticle%2FPIIS0190962210018359%2Fabstract%3Frss%3Dyes</link>
            <description>This study will use a US population–based sample of melanoma survivors and control subjects to evaluate sun-protection behaviors. (Source: Journal of the American Academy of Dermatology)</description>
            <author>Journal of the American Academy of Dermatology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5515544</comments>
            <pubDate>Mon, 19 Dec 2011 05:52:16 +0100</pubDate>
            <guid isPermaLink="false">5515544</guid>        </item>
        <item>
            <title>A torso rash and anogenital lesions</title>
            <link>http://www.medworm.com/index.php?rid=5515542&amp;cid=s_37696_12_f&amp;fid=37696&amp;url=http%3A%2F%2Fwww.eblue.org%2Farticle%2FPIIS0190962211000120%2Fabstract%3Frss%3Dyes</link>
            <description>A 36-year-old man has a mildly pruritic rash on his torso () and penile and perianal lesions of 6 weeks’ duration ( and ). He complains of fevers and malaise that have lasted for 2 weeks. His sex partners are men. An HIV test was negative 3 months ago. He has no allergies to medications. Generalized lymphadenopathy was present. A neurologic examination is normal, and he is afebrile. (Source: Journal of the American Academy of Dermatology)</description>
            <author>Journal of the American Academy of Dermatology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5515542</comments>
            <pubDate>Mon, 19 Dec 2011 05:52:16 +0100</pubDate>
            <guid isPermaLink="false">5515542</guid>        </item>
        <item>
            <title>Enlarging chest mass on a 26-year-old man</title>
            <link>http://www.medworm.com/index.php?rid=5515541&amp;cid=s_37696_12_f&amp;fid=37696&amp;url=http%3A%2F%2Fwww.eblue.org%2Farticle%2FPIIS0190962210021729%2Fabstract%3Frss%3Dyes</link>
            <description>A 26-year-old otherwise healthy Hispanic man presented with a 6-month history of an enlarging mass on the left chest wall at the site of a scar from a cactus-related injury in Mexico 10 years earlier. He began to experience pain and bleeding from the mass after the area was injured in a fight the previous night. Physical examination revealed a beefy red, lobulated ulcerated tumor with multiple adjacent pink and flesh-colored nodules that were confluent with the primary mass (). There was no regional adenopathy, and the remainder of the cutaneous examination was normal. A biopsy specimen was obtained and is shown in . Immunohistochemical staining of the tissue sample was positive for CD34 antigen. (Source: Journal of the American Academy of Dermatology)</description>
            <author>Journal of the American Academy of Dermatology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5515541</comments>
            <pubDate>Mon, 19 Dec 2011 05:52:16 +0100</pubDate>
            <guid isPermaLink="false">5515541</guid>        </item>
        <item>
            <title>Dermatology Calendar</title>
            <link>http://www.medworm.com/index.php?rid=5515540&amp;cid=s_37696_12_f&amp;fid=37696&amp;url=http%3A%2F%2Fwww.eblue.org%2Farticle%2FPIIS0190962211021566%2Fabstract%3Frss%3Dyes</link>
            <description>(Source: Journal of the American Academy of Dermatology)</description>
            <author>Journal of the American Academy of Dermatology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5515540</comments>
            <pubDate>Mon, 19 Dec 2011 05:52:16 +0100</pubDate>
            <guid isPermaLink="false">5515540</guid>        </item>
        <item>
            <title>Atlas of Mohs surgery frozen sections: Updated edition</title>
            <link>http://www.medworm.com/index.php?rid=5515539&amp;cid=s_37696_12_f&amp;fid=37696&amp;url=http%3A%2F%2Fwww.eblue.org%2Farticle%2FPIIS0190962211008553%2Fabstract%3Frss%3Dyes</link>
            <description>While performing Mohs micrographic surgery, the dermatologic surgeon serves three distinct roles in patient care: surgical oncologist, pathologist, and reconstructive surgeon. Each of these roles is critical to surgical success, but it is the role of pathologist that distinguishes the Mohs surgeon most from other cutaneous surgeons. By enabling examination of 100% of the surgical margin, the Mohs technique offers the highest cure rate for many cutaneous neoplasms. This cure rate, however, is only as robust as the knowledge and skill of the pathologist behind the scope (in this case, the Mohs surgeon) and the quality of the slides under examination. Therefore, a thorough understanding and recognition of the cutaneous neoplasms encountered under the microscope is essential. It is in this reg...</description>
            <author>Journal of the American Academy of Dermatology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5515539</comments>
            <pubDate>Mon, 19 Dec 2011 05:52:16 +0100</pubDate>
            <guid isPermaLink="false">5515539</guid>        </item>
        <item>
            <title>Hair transplantation</title>
            <link>http://www.medworm.com/index.php?rid=5515538&amp;cid=s_37696_12_f&amp;fid=37696&amp;url=http%3A%2F%2Fwww.eblue.org%2Farticle%2FPIIS0190962211006025%2Fabstract%3Frss%3Dyes</link>
            <description>As a physician who has been performing hair transplantation for 23 years, having first started with 4.5-mm plugs, taught by my mentor—who in turn was taught by Dr Norman Orentreich—and whose technique evolved through the years to what is now considered current technology with follicular unit transplantation, I greatly enjoyed reading Hair Transplantation by Drs Avram and Rogers. The field of hair transplantation has been missing a concise reference text, and Hair Transplantation fills that void. Hair Transplantation is a “soup to nuts,” well illustrated book, and the chapters are written by leaders in the field of hair transplantation. All aspects are covered: the consultation, medical treatments for hair transplantation, the donor area, hairline design, and the treatment of scarri...</description>
            <author>Journal of the American Academy of Dermatology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5515538</comments>
            <pubDate>Mon, 19 Dec 2011 05:52:16 +0100</pubDate>
            <guid isPermaLink="false">5515538</guid>        </item>
        <item>
            <title>Acne scars: Classification and treatment</title>
            <link>http://www.medworm.com/index.php?rid=5515537&amp;cid=s_37696_12_f&amp;fid=37696&amp;url=http%3A%2F%2Fwww.eblue.org%2Farticle%2FPIIS0190962210022516%2Fabstract%3Frss%3Dyes</link>
            <description>Scarring from acne is one of the most vexing problems in dermatologic surgery. Unlike other areas of cosmetics, it is borne from a medical condition and affects individuals of varying ages. It can negatively affect one’s economic and social opportunities and be devastating to self-esteem. While prevention may be the best cure, access to medical care, compliance, and the increased frequency of adult acne all increase the likelihood of scarring from inflammatory and nodulocystic acne. (Source: Journal of the American Academy of Dermatology)</description>
            <author>Journal of the American Academy of Dermatology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5515537</comments>
            <pubDate>Mon, 19 Dec 2011 05:52:16 +0100</pubDate>
            <guid isPermaLink="false">5515537</guid>        </item>
        <item>
            <title>Thyroid dysfunction and cutaneous sarcoidosis</title>
            <link>http://www.medworm.com/index.php?rid=5515536&amp;cid=s_37696_12_f&amp;fid=37696&amp;url=http%3A%2F%2Fwww.eblue.org%2Farticle%2FPIIS0190962211005494%2Fabstract%3Frss%3Dyes</link>
            <description>To the Editor: Sarcoidosis is a chronic inflammatory disorder of unknown etiology characterized by noncaseating granulomas causing infiltration and failure of multiple organ systems, including organs of the endocrine system. Thyroid dysfunction, ranging from granulomatous infiltration of the thyroid gland to autoimmune-mediated thyroid disease, has been reported in association with systemic sarcoidosis. Clinically apparent thyroid disease has been reported in less than 1% to 2.9% of patients with sarcoidosis, and previous literature suggests that thyroid disease can develop at any time during the course of sarcoidosis. Notably, autopsy results suggest a higher rate of thyroid infiltration, affecting approximately 5% of patients. (Source: Journal of the American Academy of Dermatology)</description>
            <author>Journal of the American Academy of Dermatology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5515536</comments>
            <pubDate>Mon, 19 Dec 2011 05:52:16 +0100</pubDate>
            <guid isPermaLink="false">5515536</guid>        </item>
        <item>
            <title>Assessment of hair density and caliber in Caucasian and Asian female subjects with female pattern hair loss by using the Folliscope</title>
            <link>http://www.medworm.com/index.php?rid=5515535&amp;cid=s_37696_12_f&amp;fid=37696&amp;url=http%3A%2F%2Fwww.eblue.org%2Farticle%2FPIIS0190962211005469%2Fabstract%3Frss%3Dyes</link>
            <description>To the Editor: Clinical experience and past studies have suggested that Caucasian scalp hair is more dense than Asian hair, but at the same time the terminal hair fibers are thinner in average diameter. However, most of these studies were done on a single ethnic group and did not involve a direct comparison between races within the study. (Source: Journal of the American Academy of Dermatology)</description>
            <author>Journal of the American Academy of Dermatology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5515535</comments>
            <pubDate>Mon, 19 Dec 2011 05:52:16 +0100</pubDate>
            <guid isPermaLink="false">5515535</guid>        </item>
        <item>
            <title>Reliability and prevalence of digital image skin types in the United States: Results from National Health and Nutrition Examination Survey 2003-2004</title>
            <link>http://www.medworm.com/index.php?rid=5515534&amp;cid=s_37696_12_f&amp;fid=37696&amp;url=http%3A%2F%2Fwww.eblue.org%2Farticle%2FPIIS0190962211003872%2Fabstract%3Frss%3Dyes</link>
            <description>To the Editor: The incidence of skin cancer is increasing in the United States, and individual skin color/type is one of the most important predictors of skin cancer risk. Skin typing in epidemiologic studies is usually determined by subject self-report or in-person examination. We analyzed cross-sectional questionnaire responses and digital image skin type (DIST) scores from 2691 adults between 20 and 59 years of age who participated in National Health and Nutrition Examination Survey 2003-2004. The purpose of this study was to determine the reliability of using store-forward, nonfacial digital images for the evaluation of skin types in a representative sample of the US population. Using this measure, we also report the distribution of skin types within different racial groups in the Unit...</description>
            <author>Journal of the American Academy of Dermatology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5515534</comments>
            <pubDate>Mon, 19 Dec 2011 05:52:16 +0100</pubDate>
            <guid isPermaLink="false">5515534</guid>        </item>
        <item>
            <title>The FDA final rule on labeling and effectiveness testing of sunscreens: Too little, too late?</title>
            <link>http://www.medworm.com/index.php?rid=5515533&amp;cid=s_37696_12_f&amp;fid=37696&amp;url=http%3A%2F%2Fwww.eblue.org%2Farticle%2FPIIS0190962211011686%2Fabstract%3Frss%3Dyes</link>
            <description>To the Editor: At a symposium in Texas in 1991 on the biological effects of UVA radiation, I wrote: “We do not yet know the importance of UVA with regard to photoaging…and…skin cancer…. It would seem prudent, therefore, to encourage the development of sunscreens which absorb more or less uniformly throughout the ultraviolet spectrum”. The rationale behind this thinking is that our skin has evolved to exist in harmony with the mix of wavelengths that make up the terrestrial solar spectrum. Nature understands the importance of this so that when we seek natural shade or wear clothing to protect our skin, we reduce the quantity (or intensity) of sunlight on our skin but change only minimally the quality (or spectrum). (Source: Journal of the American Academy of Dermatology)</description>
            <author>Journal of the American Academy of Dermatology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5515533</comments>
            <pubDate>Mon, 19 Dec 2011 05:52:16 +0100</pubDate>
            <guid isPermaLink="false">5515533</guid>        </item>
        <item>
            <title>A comment on mycophenolate mofetil and hydroxychloroquine: An effective treatment for recalcitrant cutaneous lupus erythematosus</title>
            <link>http://www.medworm.com/index.php?rid=5515532&amp;cid=s_37696_12_f&amp;fid=37696&amp;url=http%3A%2F%2Fwww.eblue.org%2Farticle%2FPIIS0190962211010802%2Fabstract%3Frss%3Dyes</link>
            <description>To the Editor: Sadlier et al have reported their experience with mycophenolate mofetil (MMF) in conjunction with hydroxychloroquine in 3 cases of recalcitrant cutaneous lupus. We were glad to read that MMF was similarly efficacious in their hands. We found it intriguing that the 3 reported patients responded at very low doses of MMF, ranging from 1000 to 1500 mg daily. Furthermore, Sadlier et al report a mean treatment time to clinical response of 5.6 weeks, which is a significantly shorter treatment interval than we had previously reported. The small number of cases in their report makes it difficult to draw conclusions regarding dosing or time to response. Our cohorts may also differ in terms of sun exposure and extent of disease. Nonetheless, given the experience of Sadlier et al, do...</description>
            <author>Journal of the American Academy of Dermatology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5515532</comments>
            <pubDate>Mon, 19 Dec 2011 05:52:16 +0100</pubDate>
            <guid isPermaLink="false">5515532</guid>        </item>
        <item>
            <title>Mycophenolate mofetil and hydroxychloroquine: An effective treatment for recalcitrant cutaneous lupus erythematosus</title>
            <link>http://www.medworm.com/index.php?rid=5515531&amp;cid=s_37696_12_f&amp;fid=37696&amp;url=http%3A%2F%2Fwww.eblue.org%2Farticle%2FPIIS0190962211010838%2Fabstract%3Frss%3Dyes</link>
            <description>We report 3 further cases of recalcitrant CLE that responded to combination treatment with MMF and hydroxychloroquine. (Source: Journal of the American Academy of Dermatology)</description>
            <author>Journal of the American Academy of Dermatology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5515531</comments>
            <pubDate>Mon, 19 Dec 2011 05:52:16 +0100</pubDate>
            <guid isPermaLink="false">5515531</guid>        </item>
        <item>
            <title>A definitive case of metastatic folliculotropic melanoma</title>
            <link>http://www.medworm.com/index.php?rid=5515530&amp;cid=s_37696_12_f&amp;fid=37696&amp;url=http%3A%2F%2Fwww.eblue.org%2Farticle%2FPIIS0190962211010620%2Fabstract%3Frss%3Dyes</link>
            <description>To the Editor: In the article by Hu et al, “Follicular malignant melanoma: a case report of a metastatic variant and review of the literature,” the authors speculate that this follicular melanoma was a primary tumor with sentinel lymph node metastasis. Although this is possible, their patient had two previous malignant melanomas, one of which was metastatic to regional lymph nodes. It would seem more plausible that this third melanoma was in actuality a follicular metastasis. For comparison, we present a case of melanoma that clearly metastasized to distant hair follicles. (Source: Journal of the American Academy of Dermatology)</description>
            <author>Journal of the American Academy of Dermatology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5515530</comments>
            <pubDate>Mon, 19 Dec 2011 05:52:16 +0100</pubDate>
            <guid isPermaLink="false">5515530</guid>        </item>
        <item>
            <title>Reply</title>
            <link>http://www.medworm.com/index.php?rid=5515529&amp;cid=s_37696_12_f&amp;fid=37696&amp;url=http%3A%2F%2Fwww.eblue.org%2Farticle%2FPIIS0190962211010103%2Fabstract%3Frss%3Dyes</link>
            <description>To the Editor: I would like to thank Dr. Strachan and Ms Okereke for their interest in our original research article, “Hair care practices and their association with scalp and hair disorders among African American girls.” In their letter to the Editor, one of the concerns was the study survey’s use of the layman’s term “dandruff” to describe seborrheic dermatitis, which they argue could have been misunderstood by participants. Non-infantile scalp seborrheic dermatitis (SD) can clinically present with ill-defined erythematous patches associated with fine scaling or with non-inflammatory fine white diffuse scale. Dandruff is a form of mild SD. On the survey; the actual medical term “seborrheic dermatitis” was used alongside the layman’s term “dandruff” in parentheses. P...</description>
            <author>Journal of the American Academy of Dermatology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5515529</comments>
            <pubDate>Mon, 19 Dec 2011 05:52:16 +0100</pubDate>
            <guid isPermaLink="false">5515529</guid>        </item>
        <item>
            <title>Hair care practices and their association with scalp and hair disorders in African American girls</title>
            <link>http://www.medworm.com/index.php?rid=5515528&amp;cid=s_37696_12_f&amp;fid=37696&amp;url=http%3A%2F%2Fwww.eblue.org%2Farticle%2FPIIS0190962211010115%2Fabstract%3Frss%3Dyes</link>
            <description>To the Editor: We read with great interest the article by Wright et al on the association of certain hair care practices with hair and scalp disorders in African American girls in the February 2011 issue of the Journal. The authors have made a meaningful contribution to the understanding of these conditions in an understudied demographic. We disagree, however, with some of the conclusions they come to regarding what these data suggest about seborrheic dermatitis in this population. (Source: Journal of the American Academy of Dermatology)</description>
            <author>Journal of the American Academy of Dermatology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5515528</comments>
            <pubDate>Mon, 19 Dec 2011 05:52:16 +0100</pubDate>
            <guid isPermaLink="false">5515528</guid>        </item>
        <item>
            <title>Effective use of teledermatology: Defining expectations and limitations as we move forward</title>
            <link>http://www.medworm.com/index.php?rid=5515527&amp;cid=s_37696_12_f&amp;fid=37696&amp;url=http%3A%2F%2Fwww.eblue.org%2Farticle%2FPIIS0190962211008334%2Fabstract%3Frss%3Dyes</link>
            <description>To the Editor: The American Academy of Dermatology’s recent support of teledermatology is an important step toward incorporation of a novel technology that possesses the potential to improve patient care and lead to early detection of skin cancers and other cutaneous disease. This evolution in innovation will undoubtedly spread at a rapid pace and become an integrative component of the dermatology consultation process. Before we jump on the “teledermatology bandwagon,” it is important to proceed with caution. (Source: Journal of the American Academy of Dermatology)</description>
            <author>Journal of the American Academy of Dermatology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5515527</comments>
            <pubDate>Mon, 19 Dec 2011 05:52:16 +0100</pubDate>
            <guid isPermaLink="false">5515527</guid>        </item>
        <item>
            <title>Dialogues in Dermatology: Highlights from 2011</title>
            <link>http://www.medworm.com/index.php?rid=5515525&amp;cid=s_37696_12_f&amp;fid=37696&amp;url=http%3A%2F%2Fwww.eblue.org%2Farticle%2FPIIS019096221101173X%2Fabstract%3Frss%3Dyes</link>
            <description>Dialogues in Dermatology, a monthly audio program from the American Academy of Dermatology, contains discussions between dermatologists on timely topics. Commentaries from Dialogues Editor-in-Chief Michael Girardi, MD, are provided after each discussion as a topic summary and are provided here as a special service to readers of the Journal of the American Academy of Dermatology. (Source: Journal of the American Academy of Dermatology)</description>
            <author>Journal of the American Academy of Dermatology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5515525</comments>
            <pubDate>Mon, 19 Dec 2011 05:52:16 +0100</pubDate>
            <guid isPermaLink="false">5515525</guid>        </item>
        <item>
            <title>Time for a change? Updated guidelines using interferon gamma release assays for detection of latent tuberculosis infection in the office setting</title>
            <link>http://www.medworm.com/index.php?rid=5515524&amp;cid=s_37696_12_f&amp;fid=37696&amp;url=http%3A%2F%2Fwww.eblue.org%2Farticle%2FPIIS0190962211010486%2Fabstract%3Frss%3Dyes</link>
            <description>This article discusses the advantages and disadvantages of both the TST and the IGRA and presents a summary of the Centers for Disease Control and Prevention 2010 guidelines for using IGRAs. (Source: Journal of the American Academy of Dermatology)</description>
            <author>Journal of the American Academy of Dermatology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5515524</comments>
            <pubDate>Mon, 19 Dec 2011 05:52:16 +0100</pubDate>
            <guid isPermaLink="false">5515524</guid>        </item>
        <item>
            <title>American Board of Dermatology Examination Dates</title>
            <link>http://www.medworm.com/index.php?rid=5515505&amp;cid=s_37696_12_f&amp;fid=37696&amp;url=http%3A%2F%2Fwww.eblue.org%2Farticle%2FPIIS0190962211021797%2Fabstract%3Frss%3Dyes</link>
            <description>(Source: Journal of the American Academy of Dermatology)</description>
            <author>Journal of the American Academy of Dermatology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5515505</comments>
            <pubDate>Mon, 19 Dec 2011 05:52:16 +0100</pubDate>
            <guid isPermaLink="false">5515505</guid>        </item>
        <item>
            <title>Answers to CME examination</title>
            <link>http://www.medworm.com/index.php?rid=5515504&amp;cid=s_37696_12_f&amp;fid=37696&amp;url=http%3A%2F%2Fwww.eblue.org%2Farticle%2FPIIS0190962211010747%2Fabstract%3Frss%3Dyes</link>
            <description>(Source: Journal of the American Academy of Dermatology)</description>
            <author>Journal of the American Academy of Dermatology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5515504</comments>
            <pubDate>Mon, 19 Dec 2011 05:52:16 +0100</pubDate>
            <guid isPermaLink="false">5515504</guid>        </item>
        <item>
            <title>CME examination</title>
            <link>http://www.medworm.com/index.php?rid=5515503&amp;cid=s_37696_12_f&amp;fid=37696&amp;url=http%3A%2F%2Fwww.eblue.org%2Farticle%2FPIIS0190962211010735%2Fabstract%3Frss%3Dyes</link>
            <description>(Source: Journal of the American Academy of Dermatology)</description>
            <author>Journal of the American Academy of Dermatology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5515503</comments>
            <pubDate>Mon, 19 Dec 2011 05:52:16 +0100</pubDate>
            <guid isPermaLink="false">5515503</guid>        </item>
        <item>
            <title>Cutaneous scarring: Pathophysiology, molecular mechanisms, and scar reduction therapeutics: Part II. Strategies to reduce scar formation after dermatologic procedures</title>
            <link>http://www.medworm.com/index.php?rid=5515502&amp;cid=s_37696_12_f&amp;fid=37696&amp;url=http%3A%2F%2Fwww.eblue.org%2Farticle%2FPIIS019096221101067X%2Fabstract%3Frss%3Dyes</link>
            <description>The evidence base underpinning most traditional scar reduction approaches is limited, but some of the novel strategies are promising and accumulating. We review a number of commonly adopted strategies for scar reduction. The outlined novel agents are paradigmatic of the value of translational medical research and are likely to change the scenery in the much neglected but recently revived field of scar reduction therapeutics. (Source: Journal of the American Academy of Dermatology)</description>
            <author>Journal of the American Academy of Dermatology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5515502</comments>
            <pubDate>Mon, 19 Dec 2011 05:52:16 +0100</pubDate>
            <guid isPermaLink="false">5515502</guid>        </item>
        <item>
            <title>Change of Address</title>
            <link>http://www.medworm.com/index.php?rid=5515501&amp;cid=s_37696_12_f&amp;fid=37696&amp;url=http%3A%2F%2Fwww.eblue.org%2Farticle%2FPIIS0190962211021785%2Fabstract%3Frss%3Dyes</link>
            <description>(Source: Journal of the American Academy of Dermatology)</description>
            <author>Journal of the American Academy of Dermatology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5515501</comments>
            <pubDate>Mon, 19 Dec 2011 05:52:16 +0100</pubDate>
            <guid isPermaLink="false">5515501</guid>        </item>
        <item>
            <title>Answers to CME examination</title>
            <link>http://www.medworm.com/index.php?rid=5515500&amp;cid=s_37696_12_f&amp;fid=37696&amp;url=http%3A%2F%2Fwww.eblue.org%2Farticle%2FPIIS019096221101070X%2Fabstract%3Frss%3Dyes</link>
            <description>(Source: Journal of the American Academy of Dermatology)</description>
            <author>Journal of the American Academy of Dermatology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5515500</comments>
            <pubDate>Mon, 19 Dec 2011 05:52:16 +0100</pubDate>
            <guid isPermaLink="false">5515500</guid>        </item>
        <item>
            <title>CME examination</title>
            <link>http://www.medworm.com/index.php?rid=5515499&amp;cid=s_37696_12_f&amp;fid=37696&amp;url=http%3A%2F%2Fwww.eblue.org%2Farticle%2FPIIS0190962211010693%2Fabstract%3Frss%3Dyes</link>
            <description>(Source: Journal of the American Academy of Dermatology)</description>
            <author>Journal of the American Academy of Dermatology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5515499</comments>
            <pubDate>Mon, 19 Dec 2011 05:52:16 +0100</pubDate>
            <guid isPermaLink="false">5515499</guid>        </item>
        <item>
            <title>Cutaneous scarring: Pathophysiology, molecular mechanisms, and scar reduction therapeutics: Part I. The molecular basis of scar formation</title>
            <link>http://www.medworm.com/index.php?rid=5515498&amp;cid=s_37696_12_f&amp;fid=37696&amp;url=http%3A%2F%2Fwww.eblue.org%2Farticle%2FPIIS0190962211010681%2Fabstract%3Frss%3Dyes</link>
            <description>Cutaneous scarring is often the epicenter of patient-related concerns, and the question “Will there be a scar?” is one that is all too familiar to the everyday clinician. In approaching this topic, we have reviewed the pathology, the embryology, and the molecular biology of cutaneous scarring. (Source: Journal of the American Academy of Dermatology)</description>
            <author>Journal of the American Academy of Dermatology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5515498</comments>
            <pubDate>Mon, 19 Dec 2011 05:52:16 +0100</pubDate>
            <guid isPermaLink="false">5515498</guid>        </item>
        <item>
            <title>The efficacy of trimethoprim in wound healing of patients with epidermolysis bullosa: A feasibility trial</title>
            <link>http://www.medworm.com/index.php?rid=5597871&amp;cid=s_37696_12_f&amp;fid=37696&amp;url=http%3A%2F%2Fwww.eblue.org%2Farticle%2FPIIS0190962210001337%2Fabstract%3Frss%3Dyes</link>
            <description>Conclusions: This proof-of-concept study demonstrates the potential efficacy of TMP in improving wound healing in RDEB, and provides useful information for further prospective studies. (Source: Journal of the American Academy of Dermatology)</description>
            <author>Journal of the American Academy of Dermatology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5597871</comments>
            <pubDate>Thu, 08 Dec 2011 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5597871</guid>        </item>
        <item>
            <title>Dermatology Calendar</title>
            <link>http://www.medworm.com/index.php?rid=5408263&amp;cid=s_37696_12_f&amp;fid=37696&amp;url=http%3A%2F%2Fwww.eblue.org%2Farticle%2FPIIS0190962211011431%2Fabstract%3Frss%3Dyes</link>
            <description>(Source: Journal of the American Academy of Dermatology)</description>
            <author>Journal of the American Academy of Dermatology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5408263</comments>
            <pubDate>Wed, 16 Nov 2011 21:07:47 +0100</pubDate>
            <guid isPermaLink="false">5408263</guid>        </item>
        <item>
            <title>Information for Readers</title>
            <link>http://www.medworm.com/index.php?rid=5408262&amp;cid=s_37696_12_f&amp;fid=37696&amp;url=http%3A%2F%2Fwww.eblue.org%2Farticle%2FPIIS019096221101142X%2Fabstract%3Frss%3Dyes</link>
            <description>(Source: Journal of the American Academy of Dermatology)</description>
            <author>Journal of the American Academy of Dermatology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5408262</comments>
            <pubDate>Wed, 16 Nov 2011 21:07:47 +0100</pubDate>
            <guid isPermaLink="false">5408262</guid>        </item>
        <item>
            <title>Table of Contents</title>
            <link>http://www.medworm.com/index.php?rid=5408261&amp;cid=s_37696_12_f&amp;fid=37696&amp;url=http%3A%2F%2Fwww.eblue.org%2Farticle%2FPIIS0190962211011406%2Fabstract%3Frss%3Dyes</link>
            <description>(Source: Journal of the American Academy of Dermatology)</description>
            <author>Journal of the American Academy of Dermatology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5408261</comments>
            <pubDate>Wed, 16 Nov 2011 21:07:47 +0100</pubDate>
            <guid isPermaLink="false">5408261</guid>        </item>
        <item>
            <title>Editorial Board</title>
            <link>http://www.medworm.com/index.php?rid=5408260&amp;cid=s_37696_12_f&amp;fid=37696&amp;url=http%3A%2F%2Fwww.eblue.org%2Farticle%2FPIIS0190962211011418%2Fabstract%3Frss%3Dyes</link>
            <description>(Source: Journal of the American Academy of Dermatology)</description>
            <author>Journal of the American Academy of Dermatology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5408260</comments>
            <pubDate>Wed, 16 Nov 2011 21:07:47 +0100</pubDate>
            <guid isPermaLink="false">5408260</guid>        </item>
        <item>
            <title>November iotaderma (#214)</title>
            <link>http://www.medworm.com/index.php?rid=5408259&amp;cid=s_37696_12_f&amp;fid=37696&amp;url=http%3A%2F%2Fwww.eblue.org%2Farticle%2FPIIS0190962210008935%2Fabstract%3Frss%3Dyes</link>
            <description>(Source: Journal of the American Academy of Dermatology)</description>
            <author>Journal of the American Academy of Dermatology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5408259</comments>
            <pubDate>Wed, 16 Nov 2011 21:07:47 +0100</pubDate>
            <guid isPermaLink="false">5408259</guid>        </item>
        <item>
            <title>Iotaderma #215</title>
            <link>http://www.medworm.com/index.php?rid=5408258&amp;cid=s_37696_12_f&amp;fid=37696&amp;url=http%3A%2F%2Fwww.eblue.org%2Farticle%2FPIIS0190962210005591%2Fabstract%3Frss%3Dyes</link>
            <description>(Source: Journal of the American Academy of Dermatology)</description>
            <author>Journal of the American Academy of Dermatology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5408258</comments>
            <pubDate>Wed, 16 Nov 2011 21:07:47 +0100</pubDate>
            <guid isPermaLink="false">5408258</guid>        </item>
        <item>
            <title>Lymphedema, yellow nails, and a persistent cough</title>
            <link>http://www.medworm.com/index.php?rid=5408253&amp;cid=s_37696_12_f&amp;fid=37696&amp;url=http%3A%2F%2Fwww.eblue.org%2Farticle%2FPIIS0190962210021717%2Fabstract%3Frss%3Dyes</link>
            <description>A 70-year-old woman presents with a 5-year history of discolored nails. She also reports a chronic cough with repeated episodes of sinusitis for the past 7 years. The physical examination reveals thickened, yellow fingernails and toenails, along with extensive lymphedema of her lower extremities complicated by bilateral ankle deformities ( and ). Yellow nail syndrome is a rare condition characterized by the clinical triad of lymphedema, yellow nails, and any of a number of respiratory manifestations. (Source: Journal of the American Academy of Dermatology)</description>
            <author>Journal of the American Academy of Dermatology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5408253</comments>
            <pubDate>Wed, 16 Nov 2011 21:07:47 +0100</pubDate>
            <guid isPermaLink="false">5408253</guid>        </item>
        <item>
            <title>Pustular lesions on the hand of a 5-year-old female</title>
            <link>http://www.medworm.com/index.php?rid=5408252&amp;cid=s_37696_12_f&amp;fid=37696&amp;url=http%3A%2F%2Fwww.eblue.org%2Farticle%2FPIIS0190962210021705%2Fabstract%3Frss%3Dyes</link>
            <description>A 5-year-old female develops, over the course of 3 days, tender pustules on the left index and third finger. Similar lesions had appeared at the same location during the neonatal period, which were clinically thought to be impetigo. No other skin lesions are noted, and the patient is taking no medications. The physical examination reveals small confluent vesicles and pustules on an erythematous base, with some scalloping of the edges (). Lymphadenopathy is not detected. (Source: Journal of the American Academy of Dermatology)</description>
            <author>Journal of the American Academy of Dermatology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5408252</comments>
            <pubDate>Wed, 16 Nov 2011 21:07:47 +0100</pubDate>
            <guid isPermaLink="false">5408252</guid>        </item>
        <item>
            <title>Subject index</title>
            <link>http://www.medworm.com/index.php?rid=5408251&amp;cid=s_37696_12_f&amp;fid=37696&amp;url=http%3A%2F%2Fwww.eblue.org%2Farticle%2FPIIS0190962211011674%2Fabstract%3Frss%3Dyes</link>
            <description>ABCC6  Acquired pseudoxanthoma elasticum presenting after liver transplantation (Bercovitch et al). 2011;64:873-8 (Original article) (Source: Journal of the American Academy of Dermatology)</description>
            <author>Journal of the American Academy of Dermatology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5408251</comments>
            <pubDate>Wed, 16 Nov 2011 21:07:47 +0100</pubDate>
            <guid isPermaLink="false">5408251</guid>        </item>
        <item>
            <title>Author index∗</title>
            <link>http://www.medworm.com/index.php?rid=5408250&amp;cid=s_37696_12_f&amp;fid=37696&amp;url=http%3A%2F%2Fwww.eblue.org%2Farticle%2FPIIS0190962211011662%2Fabstract%3Frss%3Dyes</link>
            <description>Abbott RA, Sahni D, Robson A, Agar N, Whittaker S, Scarisbrick JJ. Poikilodermatous mycosis fungoides: a study of its clinicopathological, immunophenotypic, and prognostic features. 2011;65:313-9 (Original article) (Source: Journal of the American Academy of Dermatology)</description>
            <author>Journal of the American Academy of Dermatology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5408250</comments>
            <pubDate>Wed, 16 Nov 2011 21:07:47 +0100</pubDate>
            <guid isPermaLink="false">5408250</guid>        </item>
        <item>
            <title>Cover Sheet for Index</title>
            <link>http://www.medworm.com/index.php?rid=5408249&amp;cid=s_37696_12_f&amp;fid=37696&amp;url=http%3A%2F%2Fwww.eblue.org%2Farticle%2FPIIS0190962211011650%2Fabstract%3Frss%3Dyes</link>
            <description>(Source: Journal of the American Academy of Dermatology)</description>
            <author>Journal of the American Academy of Dermatology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5408249</comments>
            <pubDate>Wed, 16 Nov 2011 21:07:47 +0100</pubDate>
            <guid isPermaLink="false">5408249</guid>        </item>
        <item>
            <title>JAAD Is Now on Facebook</title>
            <link>http://www.medworm.com/index.php?rid=5408248&amp;cid=s_37696_12_f&amp;fid=37696&amp;url=http%3A%2F%2Fwww.eblue.org%2Farticle%2FPIIS0190962211011613%2Fabstract%3Frss%3Dyes</link>
            <description>(Source: Journal of the American Academy of Dermatology)</description>
            <author>Journal of the American Academy of Dermatology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5408248</comments>
            <pubDate>Wed, 16 Nov 2011 21:07:47 +0100</pubDate>
            <guid isPermaLink="false">5408248</guid>        </item>
        <item>
            <title>Neonatal dermatology, 2nd ed</title>
            <link>http://www.medworm.com/index.php?rid=5408245&amp;cid=s_37696_12_f&amp;fid=37696&amp;url=http%3A%2F%2Fwww.eblue.org%2Farticle%2FPIIS0190962209012262%2Fabstract%3Frss%3Dyes</link>
            <description>It has been more than three decades since Nancy Esterly introduced neonatal dermatology as a subspecialty in its own right. Now, with the explosion in our knowledge of the genetics and basic science of skin, this field warrants a comprehensive textbook. The first edition of Neonatal Dermatology was an all-inclusive masterpiece, but the second edition exceeds its predecessor. Who could be more qualified to serve as editors of this wonderful text than the past and current editors of the journal Pediatric Dermatology? Drs Eichenfield, Frieden, and Esterly have created a truly superb textbook that should be on the shelf of every clinician who cares for children and their skin. (Source: Journal of the American Academy of Dermatology)</description>
            <author>Journal of the American Academy of Dermatology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5408245</comments>
            <pubDate>Wed, 16 Nov 2011 21:07:47 +0100</pubDate>
            <guid isPermaLink="false">5408245</guid>        </item>
        <item>
            <title>Zoledronic acid–induced cutaneous B-cell pseudolymphoma</title>
            <link>http://www.medworm.com/index.php?rid=5408244&amp;cid=s_37696_12_f&amp;fid=37696&amp;url=http%3A%2F%2Fwww.eblue.org%2Farticle%2FPIIS0190962209005179%2Fabstract%3Frss%3Dyes</link>
            <description>To the Editor: A 57-year-old white female with a history of breast cancer and positive lymph nodes underwent surgery followed by chemotherapy and radiation without complications in 2002. Three years later, metastatic disease to the spine and adrenal glands was discovered, and she was started on letrozole tablets and a bisphosphonate, zoledronic acid, intravenously. Nine months after starting the medications, she presented to our dermatology clinic with a 1-month history of mildly pruritic and edematous papules and plaques 4 mm to 1.2 cm in diameter located primarily on the right arm () but also on other extremities. Three skin biopsy specimens showed nodular lymphoid hyperplasia with no evidence of a lymphoproliferative disorder (). Immunohistochemical stains were positive for CD20, CD23, ...</description>
            <author>Journal of the American Academy of Dermatology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5408244</comments>
            <pubDate>Wed, 16 Nov 2011 21:07:47 +0100</pubDate>
            <guid isPermaLink="false">5408244</guid>        </item>
        <item>
            <title>Gemcitabine-associated Sweet syndrome–like eruption</title>
            <link>http://www.medworm.com/index.php?rid=5408243&amp;cid=s_37696_12_f&amp;fid=37696&amp;url=http%3A%2F%2Fwww.eblue.org%2Farticle%2FPIIS0190962209004952%2Fabstract%3Frss%3Dyes</link>
            <description>We report a patient with non-Hodgkin lymphoma who developed a pseudovesiculous skin rash following gemcitabine therapy. (Source: Journal of the American Academy of Dermatology)</description>
            <author>Journal of the American Academy of Dermatology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5408243</comments>
            <pubDate>Wed, 16 Nov 2011 21:07:47 +0100</pubDate>
            <guid isPermaLink="false">5408243</guid>        </item>
        <item>
            <title>Actinomycosis presenting as a destructive ulcerated plaque on the palate and gingiva</title>
            <link>http://www.medworm.com/index.php?rid=5408242&amp;cid=s_37696_12_f&amp;fid=37696&amp;url=http%3A%2F%2Fwww.eblue.org%2Farticle%2FPIIS019096220900317X%2Fabstract%3Frss%3Dyes</link>
            <description>To the Editor: Actinomycosis is a chronic bacterial infection which may present with protean manifestations. Most commonly it is a slowly progressive, indolent, indurated infiltration with multiple abscesses, fistulas, and sinuses. A less common form is acute and rapidly progressive, with fever and a fluctuating swelling that resembles a typical pyogenic infection. Cervicofacial actinomycosis is the most common manifestation of the disease, and palatal involvement is extremely rare. (Source: Journal of the American Academy of Dermatology)</description>
            <author>Journal of the American Academy of Dermatology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5408242</comments>
            <pubDate>Wed, 16 Nov 2011 21:07:47 +0100</pubDate>
            <guid isPermaLink="false">5408242</guid>        </item>
        <item>
            <title>The AC Rule for melanoma: A simpler tool for the wider community</title>
            <link>http://www.medworm.com/index.php?rid=5408241&amp;cid=s_37696_12_f&amp;fid=37696&amp;url=http%3A%2F%2Fwww.eblue.org%2Farticle%2FPIIS019096221100538X%2Fabstract%3Frss%3Dyes</link>
            <description>To the Editor: The AC Rule for melanoma (asymmetry, color variation) was conceived as a simpler tool that laypersons might use to successfully identify a melanoma. It could potentially be used for both clinical (naked eye) and dermatoscopic assessment. (Source: Journal of the American Academy of Dermatology)</description>
            <author>Journal of the American Academy of Dermatology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5408241</comments>
            <pubDate>Wed, 16 Nov 2011 21:07:47 +0100</pubDate>
            <guid isPermaLink="false">5408241</guid>        </item>
        <item>
            <title>A randomized controlled crossover trial: Lidocaine injected at a 90-degree angle causes less pain than lidocaine injected at a 45-degree angle</title>
            <link>http://www.medworm.com/index.php?rid=5408240&amp;cid=s_37696_12_f&amp;fid=37696&amp;url=http%3A%2F%2Fwww.eblue.org%2Farticle%2FPIIS0190962211004798%2Fabstract%3Frss%3Dyes</link>
            <description>This study examines the effect of angle of needle insertion (90 vs 45 degrees) during local administration of anesthetic on subjects’ pain. (Source: Journal of the American Academy of Dermatology)</description>
            <author>Journal of the American Academy of Dermatology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5408240</comments>
            <pubDate>Wed, 16 Nov 2011 21:07:47 +0100</pubDate>
            <guid isPermaLink="false">5408240</guid>        </item>
        <item>
            <title>Antibiotic susceptibility of Corynebacterium minutissimum isolated from lesions of Turkish patients with erythrasma</title>
            <link>http://www.medworm.com/index.php?rid=5408239&amp;cid=s_37696_12_f&amp;fid=37696&amp;url=http%3A%2F%2Fwww.eblue.org%2Farticle%2FPIIS019096221100377X%2Fabstract%3Frss%3Dyes</link>
            <description>To the Editor: Erythrasma is a common, chronic, cutaneous infection caused by a lipophilic and filamentous gram-positive bacillus, Corynebacterium minutissimum. In the treatment of the disease, systemic or topical erythromycin is recommended as the first choice of treatment. However, in our daily practice, we observed some cases that did not respond to erythromycin. Review of the literature showed no recent data about the antibiotic susceptibility of C minutissimum. Therefore we aimed to study the antibiotic susceptibility of C minutissimum isolated from patients with erythrasma. (Source: Journal of the American Academy of Dermatology)</description>
            <author>Journal of the American Academy of Dermatology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5408239</comments>
            <pubDate>Wed, 16 Nov 2011 21:07:47 +0100</pubDate>
            <guid isPermaLink="false">5408239</guid>        </item>
        <item>
            <title>Reply</title>
            <link>http://www.medworm.com/index.php?rid=5408238&amp;cid=s_37696_12_f&amp;fid=37696&amp;url=http%3A%2F%2Fwww.eblue.org%2Farticle%2FPIIS0190962211010073%2Fabstract%3Frss%3Dyes</link>
            <description>To the Editor: We thank Mr Kwatra for his comment and for pointing out that various statins differ with respect to certain pharmacologic parameters potentially affecting the risk of developing psoriasis. We did stratify our original analysis by individual statin exposure, but we did not report the results in detail in our publication, as statistical power was somewhat limited in certain strata. However, we display the findings in more detail, stratified by individual statin and by exposure duration (). (Source: Journal of the American Academy of Dermatology)</description>
            <author>Journal of the American Academy of Dermatology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5408238</comments>
            <pubDate>Wed, 16 Nov 2011 21:07:47 +0100</pubDate>
            <guid isPermaLink="false">5408238</guid>        </item>
        <item>
            <title>Statins differ significantly in their anti-inflammatory activity</title>
            <link>http://www.medworm.com/index.php?rid=5408237&amp;cid=s_37696_12_f&amp;fid=37696&amp;url=http%3A%2F%2Fwww.eblue.org%2Farticle%2FPIIS0190962211010085%2Fabstract%3Frss%3Dyes</link>
            <description>To the Editor: I read with interest the article by Brauchli, Jick, and Meier entitled “Statin use and risk of first-time psoriasis diagnosis.” The authors conclude that long-term exposure to statins does not reduce the risk of incident psoriasis. (Source: Journal of the American Academy of Dermatology)</description>
            <author>Journal of the American Academy of Dermatology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5408237</comments>
            <pubDate>Wed, 16 Nov 2011 21:07:47 +0100</pubDate>
            <guid isPermaLink="false">5408237</guid>        </item>
        <item>
            <title>Left-sided skin cancers on the arm from driving? Past and future lessons from Australia</title>
            <link>http://www.medworm.com/index.php?rid=5408236&amp;cid=s_37696_12_f&amp;fid=37696&amp;url=http%3A%2F%2Fwww.eblue.org%2Farticle%2FPIIS0190962211009431%2Fabstract%3Frss%3Dyes</link>
            <description>To the Editor: We thank Mr Cameron and Dr Grannis for their comments on our article describing a predominance of left-sided melanomas and Merkel cell carcinomas in the United States. Although this effect was greatest for both cancers on the arm (where ultraviolet [UV] exposure from automobile driving is most strongly asymmetrical) we agree that these data are insufficient to conclude that these excess cancers were caused by driving-associated UV exposure. Previously published data from Australia (where vehicles are driven on the left and the right arm would be closer to the window/sun) do in fact indicate that actinic keratosis incidence is higher on the right side. No studies have yet been published from Australia to examine the relative incidence of UV-associated skin cancers on the left...</description>
            <author>Journal of the American Academy of Dermatology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5408236</comments>
            <pubDate>Wed, 16 Nov 2011 21:07:47 +0100</pubDate>
            <guid isPermaLink="false">5408236</guid>        </item>
        <item>
            <title>Skin carcinogenesis and driving</title>
            <link>http://www.medworm.com/index.php?rid=5408235&amp;cid=s_37696_12_f&amp;fid=37696&amp;url=http%3A%2F%2Fwww.eblue.org%2Farticle%2FPIIS019096221100942X%2Fabstract%3Frss%3Dyes</link>
            <description>To the Editor: Paulson and colleagues have chosen a clever method to assess the influence of sun exposure on skin carcinogenesis by performing a retrospective analysis of the laterality of skin cancers. They look at the incidence of cancer in an area–the arm–known to have substantial excess sun exposure in US residents who drive automobiles, often with the left arm held out of the car window. The authors’ conclusion that the higher incidence of melanoma in the left arm is secondary to solar exposure, however, lacks a comparison control group. This weakness in the research design, however, can be easily remedied by performance of a comparable retrospective study in a nation where drivers motor on the left side of the road and expose the right, rather than left, arm to solar radiation....</description>
            <author>Journal of the American Academy of Dermatology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5408235</comments>
            <pubDate>Wed, 16 Nov 2011 21:07:47 +0100</pubDate>
            <guid isPermaLink="false">5408235</guid>        </item>
        <item>
            <title>Alopecia areata incognita</title>
            <link>http://www.medworm.com/index.php?rid=5408234&amp;cid=s_37696_12_f&amp;fid=37696&amp;url=http%3A%2F%2Fwww.eblue.org%2Farticle%2FPIIS0190962209005581%2Fabstract%3Frss%3Dyes</link>
            <description>To the Editor: I read with great interest the report of the dermoscopic features of alopecia areata incognita (AAI) by Tosti et al and the reply by Rakowska et al. As the first researcher to describe AAI, I feel entitled to participate to the discussion. What I consider AAI mimics a very severe telogen effluvium in a patient with apparently normal hair density. The pull test is impressively positive, and the facial hairs may be affected. Over months to years, diffuse hair thinning evolves, and some patients develop small glabrous areas. The likelihood of finding dystrophic hairs with a random trichogram or biopsy for histopathology is poor. The modified wash test, which collects hairs from the entire scalp, yields at least 350 terminal telogen hairs and may reveal up to 800, with occasi...</description>
            <author>Journal of the American Academy of Dermatology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5408234</comments>
            <pubDate>Wed, 16 Nov 2011 21:07:47 +0100</pubDate>
            <guid isPermaLink="false">5408234</guid>        </item>
        <item>
            <title>Change of Address</title>
            <link>http://www.medworm.com/index.php?rid=5408217&amp;cid=s_37696_12_f&amp;fid=37696&amp;url=http%3A%2F%2Fwww.eblue.org%2Farticle%2FPIIS0190962211011637%2Fabstract%3Frss%3Dyes</link>
            <description>(Source: Journal of the American Academy of Dermatology)</description>
            <author>Journal of the American Academy of Dermatology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5408217</comments>
            <pubDate>Wed, 16 Nov 2011 21:07:47 +0100</pubDate>
            <guid isPermaLink="false">5408217</guid>        </item>
        <item>
            <title>Answers to CME examination</title>
            <link>http://www.medworm.com/index.php?rid=5408216&amp;cid=s_37696_12_f&amp;fid=37696&amp;url=http%3A%2F%2Fwww.eblue.org%2Farticle%2FPIIS0190962211008644%2Fabstract%3Frss%3Dyes</link>
            <description>(Source: Journal of the American Academy of Dermatology)</description>
            <author>Journal of the American Academy of Dermatology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5408216</comments>
            <pubDate>Wed, 16 Nov 2011 21:07:47 +0100</pubDate>
            <guid isPermaLink="false">5408216</guid>        </item>
        <item>
            <title>CME examination</title>
            <link>http://www.medworm.com/index.php?rid=5408215&amp;cid=s_37696_12_f&amp;fid=37696&amp;url=http%3A%2F%2Fwww.eblue.org%2Farticle%2FPIIS0190962211008632%2Fabstract%3Frss%3Dyes</link>
            <description>(Source: Journal of the American Academy of Dermatology)</description>
            <author>Journal of the American Academy of Dermatology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5408215</comments>
            <pubDate>Wed, 16 Nov 2011 21:07:47 +0100</pubDate>
            <guid isPermaLink="false">5408215</guid>        </item>
        <item>
            <title>Spitz nevi and other Spitzoid lesions: Part II. Natural history and management</title>
            <link>http://www.medworm.com/index.php?rid=5408214&amp;cid=s_37696_12_f&amp;fid=37696&amp;url=http%3A%2F%2Fwww.eblue.org%2Farticle%2FPIIS0190962211008607%2Fabstract%3Frss%3Dyes</link>
            <description>For dermatologists, evidence-based management guidelines for Spitz tumors have not been established. Despite the lack of a standardized approach, most dermatologists recommend the excision of Spitz tumors occurring in adults and adopt more conservative measures towards pediatric cases. The histopathologic attributes and the clinical scenario are factored into management in each case. While the metastatic behavior of certain Spitz tumors is well known, the malignant potential of these lesions remains unclear because they only rarely result in negative outcomes. The risks and benefits of adjunctive measures, such as sentinel lymph node biopsy and interferon use, remain untested and are subjects of ongoing controversy. (In part II of this continuing medical education article, we will continue...</description>
            <author>Journal of the American Academy of Dermatology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5408214</comments>
            <pubDate>Wed, 16 Nov 2011 21:07:47 +0100</pubDate>
            <guid isPermaLink="false">5408214</guid>        </item>
        <item>
            <title>American Board of Dermatology Examination Dates</title>
            <link>http://www.medworm.com/index.php?rid=5408213&amp;cid=s_37696_12_f&amp;fid=37696&amp;url=http%3A%2F%2Fwww.eblue.org%2Farticle%2FPIIS0190962211011625%2Fabstract%3Frss%3Dyes</link>
            <description>(Source: Journal of the American Academy of Dermatology)</description>
            <author>Journal of the American Academy of Dermatology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5408213</comments>
            <pubDate>Wed, 16 Nov 2011 21:07:47 +0100</pubDate>
            <guid isPermaLink="false">5408213</guid>        </item>
        <item>
            <title>Answers to CME examination</title>
            <link>http://www.medworm.com/index.php?rid=5408212&amp;cid=s_37696_12_f&amp;fid=37696&amp;url=http%3A%2F%2Fwww.eblue.org%2Farticle%2FPIIS0190962211008668%2Fabstract%3Frss%3Dyes</link>
            <description>(Source: Journal of the American Academy of Dermatology)</description>
            <author>Journal of the American Academy of Dermatology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5408212</comments>
            <pubDate>Wed, 16 Nov 2011 21:07:47 +0100</pubDate>
            <guid isPermaLink="false">5408212</guid>        </item>
        <item>
            <title>CME examination</title>
            <link>http://www.medworm.com/index.php?rid=5408211&amp;cid=s_37696_12_f&amp;fid=37696&amp;url=http%3A%2F%2Fwww.eblue.org%2Farticle%2FPIIS0190962211008656%2Fabstract%3Frss%3Dyes</link>
            <description>(Source: Journal of the American Academy of Dermatology)</description>
            <author>Journal of the American Academy of Dermatology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5408211</comments>
            <pubDate>Wed, 16 Nov 2011 21:07:47 +0100</pubDate>
            <guid isPermaLink="false">5408211</guid>        </item>
        <item>
            <title>Spitz nevi and other Spitzoid lesions: Part I. Background and diagnoses</title>
            <link>http://www.medworm.com/index.php?rid=5408210&amp;cid=s_37696_12_f&amp;fid=37696&amp;url=http%3A%2F%2Fwww.eblue.org%2Farticle%2FPIIS0190962211008589%2Fabstract%3Frss%3Dyes</link>
            <description>Spitz nevi are melanocytic proliferations that are characterized by spindled and/or epithelioid nevomelanocytes. First interpreted as juvenile melanoma, these lesions were later characterized as benign and were observed to affect all age groups. Today, contrasting opinions persist regarding the fundamental benignancy versus malignancy within the spectrum of Spitz tumors. Beyond clinical outcome, this controversy has also been fueled by complex and sometimes convoluted classification schemes based on pathologic characteristics. More recently, immunophenotypic and molecular analyses have begun to clarify the etiologic nature of these tumors. Recent evidence suggests that histopathologic features that suggest more aggressiveness in Spitz tumors relate to mitoses and inflammation. (Source: Jou...</description>
            <author>Journal of the American Academy of Dermatology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5408210</comments>
            <pubDate>Wed, 16 Nov 2011 21:07:47 +0100</pubDate>
            <guid isPermaLink="false">5408210</guid>        </item>
        <item>
            <title>Correction</title>
            <link>http://www.medworm.com/index.php?rid=5515526&amp;cid=s_37696_12_f&amp;fid=37696&amp;url=http%3A%2F%2Fwww.eblue.org%2Farticle%2FPIIS0190962211011820%2Fabstract%3Frss%3Dyes</link>
            <description>Redondo P, Aguado L, Martínez-Cuesta A. Diagnosis and management of extensive vascular malformations of the lower limb: Part II. Systemic repercussions, diagnosis, and treatment. J Am Acad Dermatol 2011;65:909-23. (Source: Journal of the American Academy of Dermatology)</description>
            <author>Journal of the American Academy of Dermatology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5515526</comments>
            <pubDate>Mon, 14 Nov 2011 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5515526</guid>        </item>
        <item>
            <title>Systematic skin cancer screening in Northern Germany</title>
            <link>http://www.medworm.com/index.php?rid=5597864&amp;cid=s_37696_12_f&amp;fid=37696&amp;url=http%3A%2F%2Fwww.eblue.org%2Farticle%2FPIIS0190962210021171%2Fabstract%3Frss%3Dyes</link>
            <description>Conclusions: The project showed that large-scale systematic skin cancer screening is feasible and has the potential to reduce skin cancer burden, including mortality. Based on the results of SCREEN, a national statutory skin cancer early detection program was implemented in Germany in 2008. (Source: Journal of the American Academy of Dermatology)</description>
            <author>Journal of the American Academy of Dermatology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5597864</comments>
            <pubDate>Thu, 10 Nov 2011 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5597864</guid>        </item>
        <item>
            <title>Nonbullous neutrophilic lupus erythematosus: A newly recognized variant of cutaneous lupus erythematosus</title>
            <link>http://www.medworm.com/index.php?rid=5515515&amp;cid=s_37696_12_f&amp;fid=37696&amp;url=http%3A%2F%2Fwww.eblue.org%2Farticle%2FPIIS0190962209006045%2Fabstract%3Frss%3Dyes</link>
            <description>Conclusions: Nonbullous neutrophilic LE is an important entity to consider in the differential diagnosis of neutrophil-mediated eruptions. In addition, the histologic finding of neutrophils in the setting of lupus should alert one to the possibility of systemic disease. (Source: Journal of the American Academy of Dermatology)</description>
            <author>Journal of the American Academy of Dermatology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5515515</comments>
            <pubDate>Fri, 04 Nov 2011 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">5515515</guid>        </item>
        <item>
            <title>Diagnosis and management of extensive vascular malformations of the lower limb: Part II. Systemic repercussions, diagnosis, and treatment</title>
            <link>http://www.medworm.com/index.php?rid=5386988&amp;cid=s_37696_12_f&amp;fid=37696&amp;url=http%3A%2F%2Fwww.eblue.org%2Farticle%2FPIIS0190962211003550%2Fabstract%3Frss%3Dyes</link>
            <description>At least nine types of vascular malformations with specific clinical and radiologic characteristics must be distinguished in the lower limbs: Klippel–Trénaunay syndrome, port-wine stain with or without hypertrophy, cutis marmorata telangiectatica congenita, macrocephaly–capillary malformation, Parkes Weber syndrome, Stewart–Bluefarb syndrome, venous malformation, glomuvenous malformation, and lymphatic malformation. Extensive vascular malformations are often more complex than they appear and require a multidisciplinary therapeutic approach. Vascular malformations may be associated with underlying disease or systemic anomalies. Part II of this two-part series on the diagnosis and management of extensive vascular malformations of the lower limb highlights the systemic repercussions (b...</description>
            <author>Journal of the American Academy of Dermatology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5386988</comments>
            <pubDate>Tue, 01 Nov 2011 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">5386988</guid>        </item>
        <item>
            <title>Optimal tattoo removal in a single laser session based on the method of repeated exposures</title>
            <link>http://www.medworm.com/index.php?rid=5597872&amp;cid=s_37696_12_f&amp;fid=37696&amp;url=http%3A%2F%2Fwww.eblue.org%2Farticle%2FPIIS0190962211008152%2Fabstract%3Frss%3Dyes</link>
            <description>Background: Unwanted tattoos are treated with Q-switched lasers. Despite a series of treatments, efficacy is limited.Objective: We compared a single Q-switched laser treatment pass with 4 treatment passes separated by 20 minutes.Methods: Eighteen tattoos on 12 adults were divided in half and randomized. One half received a single treatment pass (the “conventional” method) with a Q-switched alexandrite laser (5.5 J/cm2, 755 nm, 100-nanosecond pulse duration, 3-mm spot size), and the other half received 4 treatment passes with an interval of 20 minutes between passes (the “R20” method). Tattoo lightening was compared 3 months later, by blinded evaluation of photographs. Biopsy specimens obtained before and immediately after treatment on both halves were also compared in blinded fashi...</description>
            <author>Journal of the American Academy of Dermatology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5597872</comments>
            <pubDate>Mon, 31 Oct 2011 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">5597872</guid>        </item>
        <item>
            <title>Dermatologist response rates to a mailed questionnaire: A randomized trial of monetary incentives</title>
            <link>http://www.medworm.com/index.php?rid=5515551&amp;cid=s_37696_12_f&amp;fid=37696&amp;url=http%3A%2F%2Fwww.eblue.org%2Farticle%2FPIIS0190962211003690%2Fabstract%3Frss%3Dyes</link>
            <description>This study examines the effect of cash incentives on dermatologist response to a mailed questionnaire and its cost-effectiveness. (Source: Journal of the American Academy of Dermatology)</description>
            <author>Journal of the American Academy of Dermatology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5515551</comments>
            <pubDate>Mon, 31 Oct 2011 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">5515551</guid>        </item>
        <item>
            <title>Dermatomyositis associated with generalized subcutaneous edema and Evans syndrome</title>
            <link>http://www.medworm.com/index.php?rid=5515523&amp;cid=s_37696_12_f&amp;fid=37696&amp;url=http%3A%2F%2Fwww.eblue.org%2Farticle%2FPIIS019096220901367X%2Fabstract%3Frss%3Dyes</link>
            <description>We report the case of a 52-year-old Korean woman who presented with generalized subcutaneous edema, an erythematous rash, dysphagia, and proximal muscle weakness, and subsequently developed features of Evans syndrome. Treatment with high-dose glucocorticoids and an immunosuppressive agent controlled the DM, the generalized subcutaneous edema, and the Evans syndrome. (Source: Journal of the American Academy of Dermatology)</description>
            <author>Journal of the American Academy of Dermatology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5515523</comments>
            <pubDate>Fri, 28 Oct 2011 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">5515523</guid>        </item>
        <item>
            <title>Sarcoidosis: Are there differences in your skin of color patients?</title>
            <link>http://www.medworm.com/index.php?rid=5515520&amp;cid=s_37696_12_f&amp;fid=37696&amp;url=http%3A%2F%2Fwww.eblue.org%2Farticle%2FPIIS0190962210019973%2Fabstract%3Frss%3Dyes</link>
            <description>The skin of color population is growing at an astronomical rate, making it critically important to recognize diseases, such as sarcoidosis, in patients with skin of color. Sarcoidosis is a multisystem, granulomatous disease, which manifests in a variety of organs and is found more frequently in Blacks as compared with Caucasians. In addition, Blacks have a poorer prognosis and often present with more advanced disease. Sarcoidal lesions can present with multiple morphologic features, some more common in patients with skin of color. We offer a review of the cutaneous presentations of sarcoid lesions in patients with skin of color, an overview of extracutaneous sarcoidosis, the cutaneous signs that may impact overall disease prognosis, and treatment options. (Source: Journal of the American A...</description>
            <author>Journal of the American Academy of Dermatology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5515520</comments>
            <pubDate>Mon, 17 Oct 2011 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">5515520</guid>        </item>
        <item>
            <title>Dermatology Calendar</title>
            <link>http://www.medworm.com/index.php?rid=5314666&amp;cid=s_37696_12_f&amp;fid=37696&amp;url=http%3A%2F%2Fwww.eblue.org%2Farticle%2FPIIS0190962211010255%2Fabstract%3Frss%3Dyes</link>
            <description>(Source: Journal of the American Academy of Dermatology)</description>
            <author>Journal of the American Academy of Dermatology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5314666</comments>
            <pubDate>Sat, 15 Oct 2011 05:13:32 +0100</pubDate>
            <guid isPermaLink="false">5314666</guid>        </item>
        <item>
            <title>Information for Readers</title>
            <link>http://www.medworm.com/index.php?rid=5314665&amp;cid=s_37696_12_f&amp;fid=37696&amp;url=http%3A%2F%2Fwww.eblue.org%2Farticle%2FPIIS0190962211010243%2Fabstract%3Frss%3Dyes</link>
            <description>(Source: Journal of the American Academy of Dermatology)</description>
            <author>Journal of the American Academy of Dermatology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5314665</comments>
            <pubDate>Sat, 15 Oct 2011 05:13:32 +0100</pubDate>
            <guid isPermaLink="false">5314665</guid>        </item>
        <item>
            <title>Table of Contents</title>
            <link>http://www.medworm.com/index.php?rid=5314664&amp;cid=s_37696_12_f&amp;fid=37696&amp;url=http%3A%2F%2Fwww.eblue.org%2Farticle%2FPIIS019096221101022X%2Fabstract%3Frss%3Dyes</link>
            <description>(Source: Journal of the American Academy of Dermatology)</description>
            <author>Journal of the American Academy of Dermatology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5314664</comments>
            <pubDate>Sat, 15 Oct 2011 05:13:32 +0100</pubDate>
            <guid isPermaLink="false">5314664</guid>        </item>
        <item>
            <title>Editorial Board</title>
            <link>http://www.medworm.com/index.php?rid=5314663&amp;cid=s_37696_12_f&amp;fid=37696&amp;url=http%3A%2F%2Fwww.eblue.org%2Farticle%2FPIIS0190962211010231%2Fabstract%3Frss%3Dyes</link>
            <description>(Source: Journal of the American Academy of Dermatology)</description>
            <author>Journal of the American Academy of Dermatology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5314663</comments>
            <pubDate>Sat, 15 Oct 2011 05:13:32 +0100</pubDate>
            <guid isPermaLink="false">5314663</guid>        </item>
        <item>
            <title>October iotaderma (#213)</title>
            <link>http://www.medworm.com/index.php?rid=5314662&amp;cid=s_37696_12_f&amp;fid=37696&amp;url=http%3A%2F%2Fwww.eblue.org%2Farticle%2FPIIS0190962210008492%2Fabstract%3Frss%3Dyes</link>
            <description>(Source: Journal of the American Academy of Dermatology)</description>
            <author>Journal of the American Academy of Dermatology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5314662</comments>
            <pubDate>Sat, 15 Oct 2011 05:13:31 +0100</pubDate>
            <guid isPermaLink="false">5314662</guid>        </item>
        <item>
            <title>Iotaderma #214</title>
            <link>http://www.medworm.com/index.php?rid=5314661&amp;cid=s_37696_12_f&amp;fid=37696&amp;url=http%3A%2F%2Fwww.eblue.org%2Farticle%2FPIIS019096221000887X%2Fabstract%3Frss%3Dyes</link>
            <description>(Source: Journal of the American Academy of Dermatology)</description>
            <author>Journal of the American Academy of Dermatology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5314661</comments>
            <pubDate>Sat, 15 Oct 2011 05:13:31 +0100</pubDate>
            <guid isPermaLink="false">5314661</guid>        </item>
        <item>
            <title>Refractory lipodermatosclerosis treated with intralesional platelet-rich plasma</title>
            <link>http://www.medworm.com/index.php?rid=5314660&amp;cid=s_37696_12_f&amp;fid=37696&amp;url=http%3A%2F%2Fwww.eblue.org%2Farticle%2FPIIS0190962211008498%2Fabstract%3Frss%3Dyes</link>
            <description>We report a case of lipodermatosclerosis that was refractory to conventional therapy, but was successfully treated with a platelet-rich plasma (PRP) injection.  A 76-year-old Korean man was referred to our clinic for evaluation of painful, hyperpigmented, hard, contracted skin on his left leg of 3 years’ duration. He had been previously treated with compression therapy, anabolic steroids, pentoxifylline, antibiotics, nonsteroidal anti-inflammatory drugs, and surgical intervention; however, the results were inconsistent and transient, and the skin lesions progressed to ulceration. The physical examination revealed tender, sharply demarcated, dark-red, woody, indurated plaques with central ulcerations on the lower medial third of the left leg (, A). Based on the clinical findings, the pati...</description>
            <author>Journal of the American Academy of Dermatology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5314660</comments>
            <pubDate>Sat, 15 Oct 2011 05:13:31 +0100</pubDate>
            <guid isPermaLink="false">5314660</guid>        </item>
        <item>
            <title>Cutaneous pseudolymphoma localized to black tattoo</title>
            <link>http://www.medworm.com/index.php?rid=5314659&amp;cid=s_37696_12_f&amp;fid=37696&amp;url=http%3A%2F%2Fwww.eblue.org%2Farticle%2FPIIS0190962211008486%2Fabstract%3Frss%3Dyes</link>
            <description>To the Editor: In December 2010 a 65-year-old Caucasian man presented to our dermatology department for a consultation regarding a tattoo, representing a series of numbers, on his right forearm. Although the tattoo was bluish-black in appearance, the patient reported that black ink had been used and had faded over the intervening 10 years. Closer examination revealed swelling and micronodular lesions over the entire surface of the tattoo; the patient reported that these had appeared 2 years previously (). (Source: Journal of the American Academy of Dermatology)</description>
            <author>Journal of the American Academy of Dermatology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5314659</comments>
            <pubDate>Sat, 15 Oct 2011 05:13:30 +0100</pubDate>
            <guid isPermaLink="false">5314659</guid>        </item>
        <item>
            <title>Buyer beware: A black salve caution</title>
            <link>http://www.medworm.com/index.php?rid=5314658&amp;cid=s_37696_12_f&amp;fid=37696&amp;url=http%3A%2F%2Fwww.eblue.org%2Farticle%2FPIIS0190962211008292%2Fabstract%3Frss%3Dyes</link>
            <description>We present a case that illustrates the danger of using poorly regulated online products perceived as safe and effective by the general public to treat serious dermatologic conditions. (Source: Journal of the American Academy of Dermatology)</description>
            <author>Journal of the American Academy of Dermatology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5314658</comments>
            <pubDate>Sat, 15 Oct 2011 05:13:29 +0100</pubDate>
            <guid isPermaLink="false">5314658</guid>        </item>
        <item>
            <title>Detection of Merkel cell polyomavirus in cutaneous squamous cell carcinoma before occurrence of Merkel cell carcinoma</title>
            <link>http://www.medworm.com/index.php?rid=5314657&amp;cid=s_37696_12_f&amp;fid=37696&amp;url=http%3A%2F%2Fwww.eblue.org%2Farticle%2FPIIS0190962211008255%2Fabstract%3Frss%3Dyes</link>
            <description>To the Editor: In 2008, a previously unknown polyomavirus, Merkel cell polyomavirus (MCPyV), was identified in Merkel cell carcinoma (MCC) lesions and close association between MCPyV and MCC has been suggested. However, to our knowledge, no previous reports have confirmed MCPyV infection in patients with MCC before the occurrence of MCC. We herein report a patient who developed squamous cell carcinoma (SCC) followed by MCC. MCPyV was detected in both tumors by polymerase chain reaction analysis. (Source: Journal of the American Academy of Dermatology)</description>
            <author>Journal of the American Academy of Dermatology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5314657</comments>
            <pubDate>Sat, 15 Oct 2011 05:13:29 +0100</pubDate>
            <guid isPermaLink="false">5314657</guid>        </item>
        <item>
            <title>Dermatomyositis and concomitant overlap myasthenic syndrome: A rare presentation</title>
            <link>http://www.medworm.com/index.php?rid=5314656&amp;cid=s_37696_12_f&amp;fid=37696&amp;url=http%3A%2F%2Fwww.eblue.org%2Farticle%2FPIIS0190962211008206%2Fabstract%3Frss%3Dyes</link>
            <description>We report a patient with combined DM and OMS who was ultimately diagnosed with ductal carcinoma of the breast. (Source: Journal of the American Academy of Dermatology)</description>
            <author>Journal of the American Academy of Dermatology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5314656</comments>
            <pubDate>Sat, 15 Oct 2011 05:13:28 +0100</pubDate>
            <guid isPermaLink="false">5314656</guid>        </item>
        <item>
            <title>Exercise-induced progressive pigmentary purpura of the forehead</title>
            <link>http://www.medworm.com/index.php?rid=5314655&amp;cid=s_37696_12_f&amp;fid=37696&amp;url=http%3A%2F%2Fwww.eblue.org%2Farticle%2FPIIS0190962211008188%2Fabstract%3Frss%3Dyes</link>
            <description>To the Editor: Pigmented purpuric eruptions are uncommon clinical entities representing capillaritis of unknown etiology. Herein, we describe an unusual case of exercise-induced progressive pigmentary purpura presenting on the forehead. (Source: Journal of the American Academy of Dermatology)</description>
            <author>Journal of the American Academy of Dermatology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5314655</comments>
            <pubDate>Sat, 15 Oct 2011 05:13:28 +0100</pubDate>
            <guid isPermaLink="false">5314655</guid>        </item>
        <item>
            <title>Acetretin-induced retinoic acid syndrome</title>
            <link>http://www.medworm.com/index.php?rid=5314654&amp;cid=s_37696_12_f&amp;fid=37696&amp;url=http%3A%2F%2Fwww.eblue.org%2Farticle%2FPIIS0190962211005354%2Fabstract%3Frss%3Dyes</link>
            <description>We present the second case of RAS in a patient treated for psoriasis with the aromatic retinoid acetretin. (Source: Journal of the American Academy of Dermatology)</description>
            <author>Journal of the American Academy of Dermatology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5314654</comments>
            <pubDate>Sat, 15 Oct 2011 05:13:28 +0100</pubDate>
            <guid isPermaLink="false">5314654</guid>        </item>
        <item>
            <title>An unusual clinical and histologic presentation of disseminated cutaneous histoplasmosis</title>
            <link>http://www.medworm.com/index.php?rid=5314653&amp;cid=s_37696_12_f&amp;fid=37696&amp;url=http%3A%2F%2Fwww.eblue.org%2Farticle%2FPIIS0190962210022528%2Fabstract%3Frss%3Dyes</link>
            <description>To the Editor: Histoplasmosis, an infection with the dimorphic saprophytic fungus Histoplasma capsulatum var capsulatum, occurs by either inhalation or direct cutaneous inoculation. It is the most common endemic mycosis in immunosuppressed patients, and disseminated infection in this population may lead to septic shock with multiorgan failure. Cutaneous involvement occurs in 5% to 20% of cases of disseminated histoplasmosis, and most commonly presents as papules that favor the face and chest. Other manifestations include ulcerating plaques, vesicles and pustules, pyoderma gangrenosum–like ulcers, and exanthematous eruptions. In patients with AIDS, ulcerative stomatitis is also an important presentation. (Source: Journal of the American Academy of Dermatology)</description>
            <author>Journal of the American Academy of Dermatology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5314653</comments>
            <pubDate>Sat, 15 Oct 2011 05:13:27 +0100</pubDate>
            <guid isPermaLink="false">5314653</guid>        </item>
        <item>
            <title>A nonhealing self-mutilation ulcer secondary to neonatal Erb palsy</title>
            <link>http://www.medworm.com/index.php?rid=5314652&amp;cid=s_37696_12_f&amp;fid=37696&amp;url=http%3A%2F%2Fwww.eblue.org%2Farticle%2FPIIS0190962210008121%2Fabstract%3Frss%3Dyes</link>
            <description>We report a case of an 18-month-old boy who presented to our dermatology department with a nonhealing thumb ulcer and was subsequently found to have Erb palsy. (Source: Journal of the American Academy of Dermatology)</description>
            <author>Journal of the American Academy of Dermatology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5314652</comments>
            <pubDate>Sat, 15 Oct 2011 05:13:27 +0100</pubDate>
            <guid isPermaLink="false">5314652</guid>        </item>
        <item>
            <title>Palmar and plantar keratoderma, visual loss, and alopecia</title>
            <link>http://www.medworm.com/index.php?rid=5314651&amp;cid=s_37696_12_f&amp;fid=37696&amp;url=http%3A%2F%2Fwww.eblue.org%2Farticle%2FPIIS0190962210020256%2Fabstract%3Frss%3Dyes</link>
            <description>A 33-year-old healthy man presents with a 2-month history of progressive visual loss, itching lesions on the palms and soles, and hair loss. The physical examination reveals hyperkeratotic plaques on the palms and soles (), moth-eaten alopecia (), and oropharyngeal candidiasis. An ophthalmic examination reveals panuveitis with nonreactive pupils and irregular border. The rest of his cutaneous and neurologic examination is normal. (Source: Journal of the American Academy of Dermatology)</description>
            <author>Journal of the American Academy of Dermatology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5314651</comments>
            <pubDate>Sat, 15 Oct 2011 05:13:26 +0100</pubDate>
            <guid isPermaLink="false">5314651</guid>        </item>
        <item>
            <title>Painful skin after sun exposure in a healthy child</title>
            <link>http://www.medworm.com/index.php?rid=5314650&amp;cid=s_37696_12_f&amp;fid=37696&amp;url=http%3A%2F%2Fwww.eblue.org%2Farticle%2FPIIS0190962210020244%2Fabstract%3Frss%3Dyes</link>
            <description>A healthy 4-year-old female presents with her father for the evaluation of painful skin. The child complains that her skin hurts after being out in the sun. The stinging and burning lasts approximately 30 minutes. They do not notice a rash, although questioning reveals that her complaints are associated with mild erythema. The symptoms do not improve over the course of the summer, and no other family members experience these symptoms. Her examination is notable for several faint depressed facial scars similar to pitted acne scars (), and there is subtle scarring over the first two metacarpophalangeal joints of the left hand (). (Source: Journal of the American Academy of Dermatology)</description>
            <author>Journal of the American Academy of Dermatology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5314650</comments>
            <pubDate>Sat, 15 Oct 2011 05:13:26 +0100</pubDate>
            <guid isPermaLink="false">5314650</guid>        </item>
        <item>
            <title>Fixed focal alopecia for 20 years</title>
            <link>http://www.medworm.com/index.php?rid=5314649&amp;cid=s_37696_12_f&amp;fid=37696&amp;url=http%3A%2F%2Fwww.eblue.org%2Farticle%2FPIIS019096221002164X%2Fabstract%3Frss%3Dyes</link>
            <description>Presented during the Gross and Microscopic Dermatology Symposium at the 70th Annual Meeting of the American Academy of Dermatology, San Diego, CA, March 16-20, 2011.  A healthy 28-year-old white man presented with a focal area of hair loss. He had never tried any therapy. The area had been “bald” for at least 20 years and there was no intermittent hair growth or changes to the skin. He had a history of asthma but no additional medical problems. There was no family history of hair loss or autoimmune disease. The physical examination of the left temporal scalp revealed a focal patch of normal skin lacking terminal hairs but with intact follicular ostia containing vellus hairs (). A punch biopsy specimen was obtained (). (Source: Journal of the American Academy of Dermatology)</description>
            <author>Journal of the American Academy of Dermatology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5314649</comments>
            <pubDate>Sat, 15 Oct 2011 05:13:25 +0100</pubDate>
            <guid isPermaLink="false">5314649</guid>        </item>
        <item>
            <title>Decades of progressive red and yellow nodules</title>
            <link>http://www.medworm.com/index.php?rid=5314648&amp;cid=s_37696_12_f&amp;fid=37696&amp;url=http%3A%2F%2Fwww.eblue.org%2Farticle%2FPIIS0190962210019900%2Fabstract%3Frss%3Dyes</link>
            <description>A 72-year-old white man presented to the dermatology clinic with a 23-year history of progressive red, violaceous, and yellow intradermal and subcutaneous nodules. The physical examination revealed nodules on the patient’s head, neck, trunk, arms, and legs (). No lymphadenopathy was appreciated clinically. The patient had previous biopsy specimens that were diagnosed as xanthoma, atypical regressing histiocytosis, and inflammatory xanthogranuloma, respectively. The nodules were previously treated with systemic chemotherapy, excision, local radiation therapy, and intralesional triamcinolone. A biopsy specimen revealed a dense dermal infiltrate of lymphocytes, plasma cells, and neutrophils admixed with histiocytes containing pale vacuolated cytoplasm with emperipolesis (). These histiocyte...</description>
            <author>Journal of the American Academy of Dermatology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5314648</comments>
            <pubDate>Sat, 15 Oct 2011 05:13:25 +0100</pubDate>
            <guid isPermaLink="false">5314648</guid>        </item>
        <item>
            <title>JAAD Grand Rounds quiz∗ Palmoplantar keratoderma, hypodontia, hypotrichosis, nail dystrophy, and multiple eyelid cysts</title>
            <link>http://www.medworm.com/index.php?rid=5314647&amp;cid=s_37696_12_f&amp;fid=37696&amp;url=http%3A%2F%2Fwww.eblue.org%2Farticle%2FPIIS0190962210019869%2Fabstract%3Frss%3Dyes</link>
            <description>Instructions: In answering each question, refer to the specific directions provided. Because it is often necessary to provide information occurring later in a series that gives away answers to earlier questions, please answer the questions in each series in sequence. (Source: Journal of the American Academy of Dermatology)</description>
            <author>Journal of the American Academy of Dermatology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5314647</comments>
            <pubDate>Sat, 15 Oct 2011 05:13:24 +0100</pubDate>
            <guid isPermaLink="false">5314647</guid>        </item>
        <item>
            <title>Rituximab used as a first-line single agent in the treatment of pemphigus vulgaris</title>
            <link>http://www.medworm.com/index.php?rid=5314646&amp;cid=s_37696_12_f&amp;fid=37696&amp;url=http%3A%2F%2Fwww.eblue.org%2Farticle%2FPIIS0190962210007449%2Fabstract%3Frss%3Dyes</link>
            <description>To the Editor: Pemphigus vulgaris (PV) is a life-threatening autoimmune blistering disease affecting the skin and mucosa. Patients with severe disease require high-dose, long-term corticosteroids or other immunosuppressant drugs and are often slow in achieving a remission. The adverse effects of long-term treatment with such agents are well documented and associated with a mortality of 5%. There is increasing evidence for the use of the monoclonal anti-CD20 antibody, rituximab, in the treatment of severe and refractory PV. In these reports rituximab has been used as an adjuvant agent or after other treatment modalities failed. We believe this is the first report of a patient treated with rituximab as a first-line single agent to induce a rapid sustained remission. (Source: Journal of the A...</description>
            <author>Journal of the American Academy of Dermatology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5314646</comments>
            <pubDate>Sat, 15 Oct 2011 05:13:24 +0100</pubDate>
            <guid isPermaLink="false">5314646</guid>        </item>
        <item>
            <title>Adult T-cell lymphoma/leukemia presenting as pagetoid reticulosis of the palms and soles</title>
            <link>http://www.medworm.com/index.php?rid=5314645&amp;cid=s_37696_12_f&amp;fid=37696&amp;url=http%3A%2F%2Fwww.eblue.org%2Farticle%2FPIIS0190962210002070%2Fabstract%3Frss%3Dyes</link>
            <description>To the Editor: A 40-year-old Jamaican man presented with a 6-month history of a pruritic eruption on his hands and feet. On examination, he had multiple, violaceous plaques on the palms and soles (). Biopsy revealed a lymphocytic infiltrate at the dermoepidermal junction with basal layer epidermotropism and pagetoid mononuclear cell infiltration (). The patient reported that he had been human T-cell lymphotropic virus type 1 (HTLV-1) positive since 2001.He was started on a regimen of PUVA therapy with a presumptive diagnosis of pagetoid reticulosis (Woringer-Kolopp) or mycosis fungoides palmaris et plantaris, a variant of cutaneous T-cell lymphoma. (Source: Journal of the American Academy of Dermatology)</description>
            <author>Journal of the American Academy of Dermatology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5314645</comments>
            <pubDate>Sat, 15 Oct 2011 05:13:23 +0100</pubDate>
            <guid isPermaLink="false">5314645</guid>        </item>
        <item>
            <title>A case of aggressive bullous pemphigoid associated with the defective functional variant of Fc gamma receptor IIb: Implications for pathogenesis?</title>
            <link>http://www.medworm.com/index.php?rid=5314644&amp;cid=s_37696_12_f&amp;fid=37696&amp;url=http%3A%2F%2Fwww.eblue.org%2Farticle%2FPIIS0190962209002321%2Fabstract%3Frss%3Dyes</link>
            <description>We report a case of severe BP that was homozygous for the defective allele of the FcγRIIB-Ile187Thr polymorphism. (Source: Journal of the American Academy of Dermatology)</description>
            <author>Journal of the American Academy of Dermatology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5314644</comments>
            <pubDate>Sat, 15 Oct 2011 05:13:23 +0100</pubDate>
            <guid isPermaLink="false">5314644</guid>        </item>
        <item>
            <title>Aggressive cutaneous infection with Mycobacterium marinum in two patients receiving anti–tumor necrosis factor-alfa agents</title>
            <link>http://www.medworm.com/index.php?rid=5314643&amp;cid=s_37696_12_f&amp;fid=37696&amp;url=http%3A%2F%2Fwww.eblue.org%2Farticle%2FPIIS0190962209000243%2Fabstract%3Frss%3Dyes</link>
            <description>We report two additional cases of unusually aggressive cutaneous infection with M marinum in fish tank owners receiving anti–tumor necrosis factor-alfa (TNFα) antibodies, underscoring the pitfalls of histologic diagnosis. (Source: Journal of the American Academy of Dermatology)</description>
            <author>Journal of the American Academy of Dermatology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5314643</comments>
            <pubDate>Sat, 15 Oct 2011 05:13:22 +0100</pubDate>
            <guid isPermaLink="false">5314643</guid>        </item>
        <item>
            <title>Ultraviolet A sunbeds and vitamin D</title>
            <link>http://www.medworm.com/index.php?rid=5314642&amp;cid=s_37696_12_f&amp;fid=37696&amp;url=http%3A%2F%2Fwww.eblue.org%2Farticle%2FPIIS0190962211008590%2Fabstract%3Frss%3Dyes</link>
            <description>To the Editor: The current interest in vitamin D, implicating a low vitamin D status in a range of adverse health conditions, including some cancers and autoimmune diseases, has been exploited by the cosmetic tanning industry as a positive reason for using sunbeds. For example, the chairman of the Sunbed Association, a trade organization representing sunbed operators, manufacturers, and distributors of sunbeds in the United Kingdom, writes “A few minutes 2-3 times a week on a sunbed has long been known and recommended by international experts as a viable way of securing and maintaining adequate vitamin D levels.” (Source: Journal of the American Academy of Dermatology)</description>
            <author>Journal of the American Academy of Dermatology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5314642</comments>
            <pubDate>Sat, 15 Oct 2011 05:13:21 +0100</pubDate>
            <guid isPermaLink="false">5314642</guid>        </item>
        <item>
            <title>Written action plans should be comprehensive and evidence-based</title>
            <link>http://www.medworm.com/index.php?rid=5314641&amp;cid=s_37696_12_f&amp;fid=37696&amp;url=http%3A%2F%2Fwww.eblue.org%2Farticle%2FPIIS0190962208013078%2Fabstract%3Frss%3Dyes</link>
            <description>To the Editor: I certainly applaud work towards the development of a written action plan (WAP) for atopic dermatitis as published by Chisolm et al in the Journal. However, the WAP presented by the authors has a number of limitations that suggests that this plan may be appropriate for patients only with mild disease and/or those with infrequent flares. Hydrocortisone, as recommended by the WAP authors for indefinite use, has been found in healthy skin to decrease collagen synthesis by more than 80% within 3 weeks. The clinical significance of this decrease in collagen synthesis is not known. Moreover, medium potency corticosteroids—also recommended for long-term use by the authors—decrease skin thickness by at least 6% within 4 weeks. Therefore, given no time or dosage limitations on t...</description>
            <author>Journal of the American Academy of Dermatology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5314641</comments>
            <pubDate>Sat, 15 Oct 2011 05:13:20 +0100</pubDate>
            <guid isPermaLink="false">5314641</guid>        </item>
        <item>
            <title>JAAD Is Now on Facebook</title>
            <link>http://www.medworm.com/index.php?rid=5314634&amp;cid=s_37696_12_f&amp;fid=37696&amp;url=http%3A%2F%2Fwww.eblue.org%2Farticle%2FPIIS0190962211010449%2Fabstract%3Frss%3Dyes</link>
            <description>(Source: Journal of the American Academy of Dermatology)</description>
            <author>Journal of the American Academy of Dermatology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5314634</comments>
            <pubDate>Sat, 15 Oct 2011 05:13:12 +0100</pubDate>
            <guid isPermaLink="false">5314634</guid>        </item>
        <item>
            <title>Change of Address</title>
            <link>http://www.medworm.com/index.php?rid=5314628&amp;cid=s_37696_12_f&amp;fid=37696&amp;url=http%3A%2F%2Fwww.eblue.org%2Farticle%2FPIIS0190962211010437%2Fabstract%3Frss%3Dyes</link>
            <description>(Source: Journal of the American Academy of Dermatology)</description>
            <author>Journal of the American Academy of Dermatology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5314628</comments>
            <pubDate>Sat, 15 Oct 2011 05:13:02 +0100</pubDate>
            <guid isPermaLink="false">5314628</guid>        </item>
        <item>
            <title>CME examination</title>
            <link>http://www.medworm.com/index.php?rid=5314621&amp;cid=s_37696_12_f&amp;fid=37696&amp;url=http%3A%2F%2Fwww.eblue.org%2Farticle%2FPIIS0190962211003562%2Fabstract%3Frss%3Dyes</link>
            <description>(Source: Journal of the American Academy of Dermatology)</description>
            <author>Journal of the American Academy of Dermatology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5314621</comments>
            <pubDate>Sat, 15 Oct 2011 05:12:41 +0100</pubDate>
            <guid isPermaLink="false">5314621</guid>        </item>
        <item>
            <title>Answers to CME examination</title>
            <link>http://www.medworm.com/index.php?rid=5314620&amp;cid=s_37696_12_f&amp;fid=37696&amp;url=http%3A%2F%2Fwww.eblue.org%2Farticle%2FPIIS0190962211003574%2Fabstract%3Frss%3Dyes</link>
            <description>(Source: Journal of the American Academy of Dermatology)</description>
            <author>Journal of the American Academy of Dermatology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5314620</comments>
            <pubDate>Sat, 15 Oct 2011 05:12:41 +0100</pubDate>
            <guid isPermaLink="false">5314620</guid>        </item>
        <item>
            <title>Diagnosis and management of extensive vascular malformations of the lower limb: Part II. Systemic repercusion, diagnosis, and treatment</title>
            <link>http://www.medworm.com/index.php?rid=5314619&amp;cid=s_37696_12_f&amp;fid=37696&amp;url=http%3A%2F%2Fwww.eblue.org%2Farticle%2FPIIS0190962211003550%2Fabstract%3Frss%3Dyes</link>
            <description>At least nine types of vascular malformations with specific clinical and radiologic characteristics must be distinguished in the lower limbs: Klippel–Trénaunay syndrome, port-wine stain with or without hypertrophy, cutis marmorata telangiectatica congenita, macrocephaly–capillary malformation, Parkes Weber syndrome, Stewart–Bluefarb syndrome, venous malformation, glomuvenous malformation, and lymphatic malformation. Extensive vascular malformations are often more complex than they appear and require a multidisciplinary therapeutic approach. Vascular malformations may be associated with underlying disease or systemic anomalies. Part II of this two-part series on the diagnosis and management of extensive vascular malformations of the lower limb highlights the systemic repercusions (bo...</description>
            <author>Journal of the American Academy of Dermatology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5314619</comments>
            <pubDate>Sat, 15 Oct 2011 05:12:39 +0100</pubDate>
            <guid isPermaLink="false">5314619</guid>        </item>
        <item>
            <title>American Board of Dermatology Examination Dates</title>
            <link>http://www.medworm.com/index.php?rid=5314618&amp;cid=s_37696_12_f&amp;fid=37696&amp;url=http%3A%2F%2Fwww.eblue.org%2Farticle%2FPIIS0190962211010425%2Fabstract%3Frss%3Dyes</link>
            <description>(Source: Journal of the American Academy of Dermatology)</description>
            <author>Journal of the American Academy of Dermatology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5314618</comments>
            <pubDate>Sat, 15 Oct 2011 05:12:38 +0100</pubDate>
            <guid isPermaLink="false">5314618</guid>        </item>
        <item>
            <title>Answers to CME examination</title>
            <link>http://www.medworm.com/index.php?rid=5314617&amp;cid=s_37696_12_f&amp;fid=37696&amp;url=http%3A%2F%2Fwww.eblue.org%2Farticle%2FPIIS0190962211003227%2Fabstract%3Frss%3Dyes</link>
            <description>(Source: Journal of the American Academy of Dermatology)</description>
            <author>Journal of the American Academy of Dermatology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5314617</comments>
            <pubDate>Sat, 15 Oct 2011 05:12:37 +0100</pubDate>
            <guid isPermaLink="false">5314617</guid>        </item>
        <item>
            <title>CME examination</title>
            <link>http://www.medworm.com/index.php?rid=5314616&amp;cid=s_37696_12_f&amp;fid=37696&amp;url=http%3A%2F%2Fwww.eblue.org%2Farticle%2FPIIS0190962211003215%2Fabstract%3Frss%3Dyes</link>
            <description>(Source: Journal of the American Academy of Dermatology)</description>
            <author>Journal of the American Academy of Dermatology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5314616</comments>
            <pubDate>Sat, 15 Oct 2011 05:12:36 +0100</pubDate>
            <guid isPermaLink="false">5314616</guid>        </item>
        <item>
            <title>Diagnosis and management of extensive vascular malformations of the lower limb: Part I. Clinical diagnosis</title>
            <link>http://www.medworm.com/index.php?rid=5314615&amp;cid=s_37696_12_f&amp;fid=37696&amp;url=http%3A%2F%2Fwww.eblue.org%2Farticle%2FPIIS0190962211003112%2Fabstract%3Frss%3Dyes</link>
            <description>This article highlights the differences in clinical appearance and discusses the differential diagnosis of extensive vascular malformations in an attempt to ensure earlier diagnosis and better outcomes for these patients. (Source: Journal of the American Academy of Dermatology)</description>
            <author>Journal of the American Academy of Dermatology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5314615</comments>
            <pubDate>Sat, 15 Oct 2011 05:12:31 +0100</pubDate>
            <guid isPermaLink="false">5314615</guid>        </item>
        <item>
            <title>Correction</title>
            <link>http://www.medworm.com/index.php?rid=5408246&amp;cid=s_37696_12_f&amp;fid=37696&amp;url=http%3A%2F%2Fwww.eblue.org%2Farticle%2FPIIS0190962211007274%2Fabstract%3Frss%3Dyes</link>
            <description>Stathopoulos P, Gagari E. Painful bilateral ulcerations of the hard palate. J Am Acad Dermatol 2011;65:e3.  For the article above, the authors were listed as follows: Stathopoulos Panagiotis, DDS, MD, PhD, and Gagari Eleni, DMD, DMSc. The names of the authors should have been listed as follows: Panagiotis Stathopoulos, DDS, MD, PhD, and Eleni Gagari, DMD, DMSc. We apologize for the error. (Source: Journal of the American Academy of Dermatology)</description>
            <author>Journal of the American Academy of Dermatology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5408246</comments>
            <pubDate>Tue, 20 Sep 2011 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">5408246</guid>        </item>
    </channel>
</rss>

